| EOS-AX3963 | GSK1838705A | 1116235-97-2 | C27H29FN8O3 | 532.57 | CNC(=O)C1=C(C=CC=C1F)NC2=NC(=NC3=C2C=CN3)NC4=C(C=C5CCN(C5=C4)C(=O)CN(C)C)OC |
| EOS-AX3964 | GSK461364 | 929095-18-1 | C27H28F3N5O2S | 543.6 | CC(C1=CC=CC=C1C(F)(F)F)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)CN5CCN(CC5)C)C(=O)N |
| EOS-AX3965 | Guaifensin | 93-14-1 | C10H14O4 | 198.22 | COC1=CC=CC=C1OCC(CO)O |
| EOS-AX3966 | Guanethidine Sulfate | 60-02-6 | C20H44N8.H2O4S | 494.7 | C1CCCN(CCC1)CCN=C(N)N.C1CCCN(CCC1)CCN=C(N)N.OS(=O)(=O)O |
| EOS-AX3967 | GW3965 HCl | 405911-17-3 | C33H31ClF3NO3.HCl | 618.51 | C1=CC=C(C=C1)C(CN(CCCOC2=CC=CC(=C2)CC(=O)O)CC3=C(C(=CC=C3)C(F)(F)F)Cl)C4=CC=CC=C4.Cl |
| EOS-AX3968 | HLG919 | | | | |
| EOS-AX3969 | Ibuprofen | 15687-27-1 | C13H18O2 | 206.28 | CC(C)CC1=CC=C(C=C1)C(C)C(=O)O |
| EOS-AX3970 | Imidapril HCl | 89396-94-1 | C20H27N3O6.HCl | 441.91 | CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C2=O)C)C(=O)O.Cl |
| EOS-AX3971 | INCB28060 | 1029712-80-8 | C23H17FN6O | 412.42 | CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F |
| EOS-AX3972 | Indomethacin | 53-86-1 | C19H16ClNO4 | 357.79 | CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O |
| EOS-AX3973 | | | | | |
| EOS-AX3974 | Ipratropium Bromide | 22254-24-6 | C20H30BrNO3 | 412.37 | CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.[Br-] |
| EOS-AX3975 | ODM-201 | 1297538-32-9 | C19H19ClN6O2 | 398.85 | N#CC1=C(Cl)C=C(C2=NN(C[C@H](C)NC(C3=NNC(C(O)C)=C3)=O)C=C2)C=C1 |
| EOS-AX3976 | Isradipine (Dynacirc) | 75695-93-1 | C19H21N3O5 | 371.39 | CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC |
| EOS-AX3977 | Istradefylline (KW-6002) | 155270-99-8 | C20H24N4O4 | 384.43 | CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C |
| EOS-AX3978 | Nilvadipine | 75530-68-6 | C19H19N3O6 | 385.37 | CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C |
| EOS-AX3979 | JTC-801 | 244218-51-7 | C26H25N3O2.HCl | 447.96 | CCC1=CC=C(C=C1)OCC2=CC=CC=C2C(=O)NC3=CC4=C(C=C3)N=C(C=C4N)C.Cl |
| EOS-AX3980 | Ku2449 | | | | |
| EOS-AX3981 | Lamivudine | 134678-17-4 | C8H11N3O3S | 229.26 | C1C(OC(S1)CO)N2C=CC(=NC2=O)N |
| EOS-AX3982 | Laquinimod (ABR-215062) | 248281-84-7 | C19H17ClN2O3 | 356.8 | CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O |
| EOS-AX3983 | Levodopa | 59-92-7 | C9H11NO4 | 197.19 | C1=CC(=C(C=C1CC(C(=O)O)N)O)O |
| EOS-AX3984 | L-Glutamine | 56-85-9 | C5H10N2O3 | 146.14 | C(CC(=O)N)C(C(=O)O)N |
| EOS-AX3985 | Lithium Citrate | 6080-58-6 | C6H5O7.4H2O.3Li | 281.98 | [Li+].[Li+].[Li+].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.O.O.O.O |
| EOS-AX3986 | Lithocholic Acid | 434-13-9 | C24H40O3 | 376.57 | CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C |
| EOS-AX3987 | LY2109761 | 700874-71-1 | C26H27N5O2 | 441.52 | C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6 |
| EOS-AX3988 | LY2886721 | 1262036-50-9 | C18H16F2N4O2S | 390.41 | C1C2CSC(=NC2(CO1)C3=C(C=CC(=C3)NC(=O)C4=NC=C(C=C4)F)F)N |
| EOS-AX3989 | Meloxicam (Mobic) | 71125-38-7 | C14H13N3O4S2 | 351.4 | CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O |
| EOS-AX3990 | Mepenzolate Bromide | 76-90-4 | C21H26BrNO3 | 420.34 | C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C.[Br-] |
| EOS-AX3991 | Mepiroxol | 6968-72-5 | C6H7NO2 | 125.13 | C1=CC(=C[N+](=C1)[O-])CO |
| EOS-AX3992 | Mesna | 19767-45-4 | C2H5NaO3S2 | 164.18 | C(CS(=O)(=O)[O-])S.[Na+] |
| EOS-AX3993 | Mestranol | 72-33-3 | C21H26O2 | 310.43 | CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC |
| EOS-AX3994 | Meticrane | 1084-65-7 | C10H13NO4S2 | 275.34 | CC1=C(C=C2C(=C1)CCCS2(=O)=O)S(=O)(=O)N |
| EOS-AX3995 | Methimazole | 60-56-0 | C4H6N2S | 114.17 | CN1C=CNC1=S |
| EOS-AX3996 | Methyocarbamol | 532-03-6 | C11H15NO5 | 241.24 | COC1=CC=CC=C1OCC(COC(=O)N)O |
| EOS-AX3997 | Mirabegron (YM178) | 223673-61-8 | C21H24N4O2S | 396.51 | C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O |
| EOS-AX3998 | Mitotane (Lsodren) | 53-19-0 | C14H10Cl4 | 320.04 | C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl |
| EOS-AX3999 | MK-2461 | 917879-39-1 | C24H25N5O5S | 495.55 | CN1C=C(C=N1)C2=CN=C3C=CC4=C(C=C(C=C4)NS(=O)(=O)N(C)CC5COCCO5)C(=O)C3=C2 |
| EOS-AX4000 | MK-8776 (SCH-900776) | 891494-63-6 | C15H18BrN7 | 376.25 | BrC(C([C@@H]1CCCNC1)=N2)=C(N)N3C2=C(C4=CN(C)N=C4)C=N3 |
| EOS-AX4001 | Monobenzone | 103-16-2 | C13H12O2 | 200.23 | C1=CC=C(C=C1)COC2=CC=C(C=C2)O |
| EOS-AX4002 | Noscapine HCl | 912-60-7 | C22H23NO7.HCl | 449.88 | CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3.Cl |
| EOS-AX4003 | Necrostatin | | | | |
| EOS-AX4004 | Nevirapine | 129618-40-2 | C15H14N4O | 266.3 | CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4 |
| EOS-AX4005 | Nicotine Difartrate | 65-31-6 | C21H29NO4S | 462.46 | CN1CCCC1C2=CN=CC=C2.C(C(C(=O)O)O)(C(=O)O)O.C(C(C(=O)O)O)(C(=O)O)O |
| EOS-AX4006 | Nifenazone | 2139-47-1 | C17H16N4O2 | 308.33 | CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)C3=CN=CC=C3 |
| EOS-AX4007 | Nimodipine | 66085-59-4 | C21H26N2O7 | 418.45 | CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC |
| EOS-AX4008 | Nitazoxanide | 55981-09-4 | C12H9N3O5S | 307.28 | CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-] |
| EOS-AX4009 | Nitrofurazone | 59-87-0 | C6H6N4O4 | 198.14 | C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N |
| EOS-AX4010 | Nocodazole | 31430-18-9 | C14H11N3O3S | 301.32 | COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CS3 |
| EOS-AX4011 | NVP-BGT226 | 1245537-68-1 | C28H25F3N6O2.C4H4O4 | 650.6 | CN1C2=CN=C3C=CC(=CC3=C2N(C1=O)C4=CC(=C(C=C4)N5CCNCC5)C(F)(F)F)C6=CN=C(C=C6)OC.C(=CC(=O)O)C(=O)O |
| EOS-AX4012 | NVP-BVU972 | 1185763-69-2 | C20H16N6 | 340.38 | CN1C=C(C=N1)C2=NN3C(=NC=C3CC4=CC5=C(C=C4)N=CC=C5)C=C2 |
| EOS-AX4013 | Olsalazine Sodium | 6054-98-4 | C14H8N2O6.2Na | 346.2 | C1=CC(=C(C=C1NN=C2C=CC(=O)C(=C2)C(=O)O)C(=O)[O-])[O-].[Na+].[Na+] |
| EOS-AX4014 | Olsalazine Solium | | | | |
| EOS-AX4015 | Orlistat | 96829-58-2 | C29H53NO5 | 495.73 | CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O |
| EOS-AX4016 | Oxeladin Citrate | 52432-72-1 | C20H33NO3.C6H8O7 | 527.6 | CCC(CC)(C1=CC=CC=C1)C(=O)OCCOCCN(CC)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
| EOS-AX4017 | Oxethazaine | 126-27-2 | C28H41N3O3 | 467.64 | CC(C)(CC1=CC=CC=C1)N(C)C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC2=CC=CC=C2 |
| EOS-AX4018 | Oxybutynin | 5633-20-5 | C22H31NO3 | 357.49 | CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O |
| EOS-AX4019 | Paliperidone | 144598-75-4 | C23H27FN4O3 | 426.48 | CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F |
| EOS-AX4020 | Pasiniazid | 2066-89-9 | C6H7N3O.C7H7NO3 | 290.27 | C1=CC(=C(C=C1N)O)C(=O)O.C1=CN=CC=C1C(=O)NN |
| EOS-AX4021 | Pentamidine | 100-33-4 | C19H24N4O2 | 340.42 | C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N |
| EOS-AX4022 | PF-04691502 | 1013101-36-4 | C22H27N5O4 | 425.48 | CC1=C2C=C(C(=O)N(C2=NC(=N1)N)C3CCC(CC3)OCCO)C4=CN=C(C=C4)OC |
| EOS-AX4023 | PF-5274857 | 1373615-35-0 | C20H25ClN4O3S | 436.96 | CC1=CC(=C(N=C1)C2=CC(=NC=C2Cl)N3CCN(CC3)C(=O)CCS(=O)(=O)C)C |
| EOS-AX4024 | PHA-848125 | 802539-81-7 | C25H32N8O | 460.57 | CC1(CC2=CN=C(N=C2C3=C1C(=NN3C)C(=O)NC)NC4=CC=C(C=C4)N5CCN(CC5)C)C |
| EOS-AX4025 | Piromidic Acid | 19562-30-2 | C14H16N4O3 | 288.32 | CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCCC3)C(=O)O |
| EOS-AX4026 | Piroxicam | 36322-90-4 | C15H13N3O4S | 331.35 | CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3 |
| EOS-AX4027 | Pitavastatin Calcium | 147526-32-7 | C50H46CaF2N2O8 | 880.98 | C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2] |
| EOS-AX4028 | PKI-402 | 1173204-81-3 | C29H34N10O3 | 570.65 | CCN1C2=C(C(=NC(=N2)C3=CC=C(C=C3)NC(=O)NC4=CC=C(C=C4)C(=O)N5CCN(CC5)C)N6CCOCC6)N=N1 |
| EOS-AX4029 | Potassium Canrenoate | 2181-04-6 | C22H29KO4 | 396.56 | CC12CCC(=O)C=C1C=CC3C2CCC4(C3CCC4(CCC(=O)[O-])O)C.[K+] |
| EOS-AX4030 | Pridinol Methanesulfonate | 6856-31-1 | C21H29NO4S | 391.52 | CS(=O)(=O)O.C1CCN(CC1)CCC(C2=CC=CC=C2)(C3=CC=CC=C3)O |
| EOS-AX4031 | Prochlorperazine | 58-38-8 | C20H24ClN3S | 373.94 | CN(CC1)CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4 |
| EOS-AX4032 | Progesterone | 57-83-0 | C21H30O2 | 314.46 | CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C |
| EOS-AX4033 | Ranolazine | 95635-55-5 | C24H33N3O4 | 427.54 | CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O |
| EOS-AX4034 | Rapaglinide | | | | |
| EOS-AX4035 | Rifaximin (Xifaxan) | 80621-81-4 | C43H51N3O11 | 785.88 | O[C@@H]([C@H](C)[C@H]([C@H](/C=C/C=C(C)\C(NC1=C2O)=O)C)O)[C@@H](C)[C@@H]([C@H](C)[C@H](/C=C/O[C@@](C3=O)(C)OC4=C3C(C5=C1N(C=CC(C)=C6)C6=N5)=C2C(O)=C4C)OC)OC(C)=O |
| EOS-AX4036 | Riluzole | 1744-22-5 | C8H5F3N2OS | 234.2 | C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N |
| EOS-AX4037 | Risperidone | 106266-06-2 | C23H27FN4O2 | 410.48 | CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F |
| EOS-AX4038 | Rivastigmine Tartrate | 129101-54-8 | C14H22N2O2.C4H6O6 | 400.42 | CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C.C(C(C(=O)O)O)(C(=O)O)O |
| EOS-AX4039 | Rizatriptan Benzoate | 145202-66-0 | C15H19N5.C7H6O2 | 391.47 | CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O |
| EOS-AX4040 | Rofumilest(DAXAS) | | | | |
| EOS-AX4041 | Rosuvastatin Calcium | 147098-20-2 | C44H54F2N6O12S2 Ca | 1001.14 | CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca+2] |
| EOS-AX4042 | SB705498 | 501951-42-4 | C17H16BrF3N4O | 429.23 | C1CN(CC1NC(=O)NC2=CC=CC=C2Br)C3=NC=C(C=C3)C(F)(F)F |
| EOS-AX4043 | SCH727965 | | | | |
| EOS-AX4044 | Silodosin | 160970-54-7 | C25H32F3N3O4 | 495.53 | CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F |
| EOS-AX4045 | Simvastatin (Zocor) | 79902-63-9 | C25H38O5 | 418.6 | CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C |
| EOS-AX4046 | Sodium 4-amiropparaty Hyalrate | 94-16-6 | C9H9N2NaO3 | 216.17 | C1=CC(=CC=C1C(=O)NCC(=O)[O-])N.[Na+] |
| EOS-AX4047 | Sodium Orthovanadate | 13721-39-6 | Na3O4V | 183.91 | [O-][V](=O)([O-])[O-].[Na+].[Na+].[Na+] |
| EOS-AX4048 | Sotrastaurin (AEB071) | 425637-18-9 | C25H22N6O2 | 438.48 | CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65 |
| EOS-AX4049 | Strontium Ranelate | 135459-87-9 | C12H6N2O8S.2Sr | 513.49 | C(C1=C(SC(=C1C#N)N(CC(=O)O)CC(=O)O)C(=O)O)C(=O)O.[Sr].[Sr] |
| EOS-AX4050 | Sulfadiazine | 68-35-9 | C10H10N4O2S | 250.28 | C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N |
| EOS-AX4051 | TAK-285 | 871026-44-7 | C26H25ClF3N5O3 | 547.96 | CC(C)(CC(=O)NCCN1C=CC2=C1C(=NC=N2)NC3=CC(=C(C=C3)OC4=CC=CC(=C4)C(F)(F)F)Cl)O |
| EOS-AX4052 | Tebipenempivoxil | 161715-24-8 | C22H31N3O6S2 | 497.63 | CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)C(C)O |
| EOS-AX4053 | Telbivudine | 3424-98-4 | C10H14N2O5 | 242.23 | CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O |
| EOS-AX4054 | Telmisattan | 144701-48-4 | C33H30N4O2 | 514.62 | CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C |
| EOS-AX4055 | Teniposide | 29767-20-2 | C32H32O13S | 656.7 | COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O |
| EOS-AX4056 | Terbinafine | 91161-71-6 | C21H25N | 291.43 | CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21 |
| EOS-AX4057 | Terfenadine | 50679-08-8 | C32H41NO2 | 471.67 | CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O |
| EOS-AX4058 | Tetraethylenepentamine 5HCl | 4961-41-5 | C8H23N5.5HCl | 371.61 | C(CNCCNCCNCCN)N.Cl.Cl.Cl.Cl.Cl |
| EOS-AX4059 | Thiabendazole | 148-79-8 | C10H7N3S | 201.25 | C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3 |
| EOS-AX4060 | Thioridazine HCl | 130-61-0 | C21H26N2S2.HCl | 407 | CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC.Cl |
| EOS-AX4061 | Tiopronin (Thiola) | 1953-02-2 | C5H9NO3S | 163.19 | CC(C(=O)NCC(=O)O)S |
| EOS-AX4062 | Tretinoin (Aberela) | 302-79-4 | C20H28O2 | 300.4 | CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C |
| EOS-AX4063 | Triamcinolone Acetonide | 76-25-5 | C24H31FO6 | 434.5 | F[C@@]1([C@@](C([H])([H])[H])(C([H])=C2[H])C3=C([H])C2=O)[C@](C([H])([H])C3([H])[H])([H])[C@@]4([H])[C@@](C([H])([H])[C@]1([H])O[H])(C([H])([H])[H])[C@]5(C(C([H])([H])O[H])=O)OC(C([H])([H])[H])(C([H])([H])[H])O[C@]5([H])C4([H])[H] |
| EOS-AX4064 | Triciribine | 35943-35-2 | C13H16N6O4 | 320.3 | [H][C@](N1C(N=C([H])N=C2N(C([H])([H])[H])N=C3N([H])[H])=C2C3=C1[H])([C@]4([H])O[H])O[C@@](C([H])([H])O[H])([H])[C@@]4([H])O[H] |
| EOS-AX4065 | Triflurdine (Viroptic) | 70-00-8 | C10H11F3N2O5 | 296.2 | C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O |
| EOS-AX4066 | Vitamin D2 (Ergocalciferol) | 50-14-6 | C28H44O | 396.65 | CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C |
| EOS-AX4067 | Wortmannin | 19545-26-7 | C23H24O8 | 428.43 | O=C1[C@](C([H])([H])[C@@]2([H])OC(C([H])([H])[H])=O)(C([H])([H])[H])[C@](C([H])([H])C1([H])[H])([H])C(C3=O)=C2[C@]4(C([H])([H])[H])C5=C3OC([H])=C5C(O[C@]4([H])C([H])([H])OC([H])([H])[H])=O |
| EOS-AX4068 | ZM336372 | 208260-29-1 | C23H23N3O3 | 389.4 | CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)N(C)C)NC(=O)C3=CC=C(C=C3)O |
| EOS-AX4069 | R406 | 841290-81-1 | C22H23FN6O5.C6H6O3S | 628.63 | CC1(C(=O)NC2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)O |
| EOS-AX4070 | Tubastatin A HCl | 1310693-92-5 | C20H21N3O2.HCl | 371.86 | CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO.Cl |
| EOS-AX4071 | Fingolimod (FTY720) | 162359-56-0 | C19H34ClNO2 | 343.94 | CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl |
| EOS-AX4072 | LY335979 (Zosuquidar 3HCL) | 167465-36-3 | C32H34Cl3F2N3O2 | 637 | FC1([C@H](C2=CC=CC=C23)[C@@H]1C4=CC=CC=C4[C@H]3N5CCN(C[C@H](COC6=C7C(N=CC=C7)=CC=C6)O)CC5)F.Cl.Cl.Cl |
| EOS-AX4073 | Telatinib (BAY 57-9352) | 332012-40-5 | C20H16ClN5O3 | 409.83 | CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl |
| EOS-AX4074 | INK 128 (MLN0128) | 1224844-38-5 | C15H15N7O | 309.33 | CC(C)N1C2=C(C(=N1)C3=CC4=C(C=C3)OC(=N4)N)C(=NC=N2)N |
| EOS-AX4075 | PTC124 (Ataluren) | 775304-57-9 | C15H9FN2O3 | 284.24 | C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F |
| EOS-AX4076 | Dapivirine (TMC120) | 244767-67-7 | C20H19N5 | 329.4 | CC1=CC(=C(C(=C1)C)NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C |
| EOS-AX4077 | Vandetanib (ZD6474) | 443913-73-3 | C22H24BrFN4O2 | 475.35 | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
| EOS-AX4078 | GSK2126458 | 1086062-66-9 | C25H17F2N5O3S | 505.5 | COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F |
| EOS-AX4079 | TAE226 (NVP-TAE226) | 761437-28-9 | C23H25ClN6O3 | 468.94 | CNC(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCOCC4)OC |
| EOS-AX4080 | BI6727 (Volasertib) | 755038-65-4 | C34H50N8O3 | 618.83 | CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C |
| EOS-AX4081 | Purvalanol B | 212844-54-7 | C20H25ClN6O3 | 432.9 | CC(C)C(CO)NC1=NC2=C(C(=N1)NC3=CC(=C(C=C3)C(=O)O)Cl)N=CN2C(C)C |
| EOS-AX4082 | GSK744 (S/GSK1265744) | 1051375-10-0 | C19H17F2N3O5 | 405.35 | FC1=CC(F)=CC=C1CNC(C2=CN(C3=C(C2=O)O)C[C@H]4OC[C@H](C)N4C3=O)=O |
| EOS-AX4083 | Tenovin-3 | 1011301-27-1 | C18H21N3OS | 327.44 | CC(C)(C)C1=CC=C(C=C1)C(=O)NC(=S)NC2=CC=C(C=C2)N |
| EOS-AX4084 | Tankyrase Inhibitors (TNKS) 22 | | C25H25N5O3S | 475.56 | O=C1NC(SCCC(N[C@H]2CC[C@H](C3=NN=C(C4=CC=CC=C4)O3)CC2)=O)=NC5=CC=CC=C51 |
| EOS-AX4085 | Tankyrase Inhibitors (TNKS) 49 | | C24H24N4O3S | 448.54 | O=C1NC(SCCC(N[C@H]2CC[C@H](OC3=CC=C(C#N)C=C3)CC2)=O)=NC4=CC=CC=C41 |
| EOS-AX4086 | Adaphostin | 241127-58-2 | C24H27NO4 | 393.48 | C1C2CC3CC1CC(C2)(C3)OC(=O)C4=CC=C(C=C4)NCC5=C(C=CC(=C5)O)O |
| EOS-AX4087 | GNF 2 | 778270-11-4 | C18H13F3N4O2 | 374.32 | C1=CC(=CC(=C1)C(=O)N)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F |
| EOS-AX4088 | GNF 5 | 778277-15-9 | C20H17F3N4O3 | 418.37 | C1=CC(=CC(=C1)C(=O)NCCO)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F |
| EOS-AX4089 | 1-Naphthyl PP1 | 221243-82-9 | C19H19N5 | 317.39 | CC(C)(C)N1C2=C(C(=N1)C3=CC=CC4=CC=CC=C43)C(=NC=N2)N |
| EOS-AX4090 | PD 180970 | 287204-45-9 | C21H15Cl2FN4O | 429.27 | CC1=C(C=CC(=C1)NC2=NC=C3C=C(C(=O)N(C3=N2)C)C4=C(C=CC=C4Cl)Cl)F |
| EOS-AX4091 | PPY A | 875634-01-8 | C22H20N4O2 | 372.42 | CN(C)C(=O)C1=CN=CC(=C1)C2=CN=C3C(=C2)C(=CN3)C4=CC=CC=C4OC |
| EOS-AX4092 | CH 223191 | 301326-22-7 | C19H19N5O | 333.39 | CC1=CC=CC=C1N=NC2=CC(=C(C=C2)NC(=O)C3=CC=NN3C)C |
| EOS-AX4093 | 6,2',4'-Trimethoxyflavone | 720675-74-1 | C18H16O5 | 312.32 | O=C1C2=C(C=CC(OC)=C2)OC(C3=CC=C(OC)C=C3OC)=C1 |
| EOS-AX4094 | MeBIO | 667463-95-8 | C17H12BrN3O2 | 370.2 | CN1C2=C(C=CC(=C2)Br)C(=C3C(=C4C=CC=CC4=N3)NO)C1=O |
| EOS-AX4095 | L-Kynurenine | 2922-83-0 | C10H12N2O3 | 208.21 | C1=CC=C(C(=C1)C(=O)CC(C(=O)O)N)N |
| EOS-AX4096 | DiMNF | 14756-24-2 | C21H16O4 | 332.35 | COC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3)OC |
| EOS-AX4097 | Phortress | 328087-38-3 | C20H23FN4OS.2HCl | 459.41 | O=C([C@@H](N)CCCCN)NC1=C(C)C=C(C=C1)C2=NC3=C(S2)C=CC(F)=C3.Cl.Cl |
| EOS-AX4098 | ITE | 448906-42-1 | C14H10N2O3S | 286.3 | COC(=O)C1=CSC(=N1)C(=O)C2=CNC3=CC=CC=C32 |
| EOS-AX4099 | A-674563 | 552325-73-2 | C22H22N4O | 358.44 | CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OCC(CC4=CC=CC=C4)N |
| EOS-AX4100 | CCT128930 | 885499-61-6 | C18H20ClN5 | 341.84 | C1CN(CCC1(CC2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4 |
| EOS-AX4101 | Palomid 529 | 914913-88-5 | C24H22O6 | 406.43 | CC(C1=CC2=C(C=C1)C3=CC(=C(C=C3OC2=O)OCC4=CC=C(C=C4)OC)OC)O |
| EOS-AX4102 | TIC10 | 41276-02-2 | C24H26N4O | 386.49 | O=C1N2C(N(C([H])([H])C3=C([H])C([H])=C([H])C([H])=C3C([H])([H])[H])C4=C1C([H])([H])N(C([H])([H])C5=C([H])C([H])=C([H])C([H])=C5[H])C([H])([H])C4([H])[H])=NC([H])([H])C2([H])[H] |
| EOS-AX4103 | AZD-3463 | 1356962-20-3 | C24H25ClN6O | 448.95 | COC1=C(C=CC(=C1)N2CCC(CC2)N)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl |
| EOS-AX4104 | Bestatin hydrochloride | 65391-42-6 | C16H25ClN2O4 | 344.83 | CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O.Cl |
| EOS-AX4105 | Bestatin trifluoroacetate | 223763-80-2 | C18H25F3N2O6 | 422.4 | |
| EOS-AX4106 | TOK-001 | 851983-85-2 | C26H32N2O | 388.56 | CC12CCC(CC1=CCC3C2CCC4(C3CC=C4N5C=NC6=CC=CC=C65)C)O |
| EOS-AX4107 | CGK733 | 905973-89-9 | C23H18Cl3FN4O3S | 555.84 | C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC3=CC(=C(C=C3)F)[N+](=O)[O-] |
| EOS-AX4108 | CP-466722 | 1080622-86-1 | C17H15N7O2 | 349.35 | COC1=C(C=C2C(=C1)C(=NC=N2)N3C(=NC(=N3)C4=CC=CC=N4)N)OC |
| EOS-AX4109 | ETP-46464 | 1345675-02-6 | C30H22N4O2 | 470.52 | CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3COC2=O)C5=CC6=CC=CC=C6N=C5 |
| EOS-AX4110 | Bafilomycin A1 | 88899-55-2 | C35H58O9 | 622.84 | CC1CC(=CC=CC(C(OC(=O)C(=CC(=CC(C1O)C)C)OC)C(C)C(C(C)C2(CC(C(C(O2)C(C)C)C)O)O)O)OC)C |
| EOS-AX4111 | Chloroquine diphosphate | 50-63-5 | C18H26ClN3.2H3PO4 | 515.86 | CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O |
| EOS-AX4112 | DBeQ | 177355-84-9 | C22H20N4 | 340.42 | C1=CC=C(C=C1)CNC2=NC(=NC3=CC=CC=C32)NCC4=CC=CC=C4 |
| EOS-AX4113 | Xanthohumol | 6754-58-1 | C21H22O5 | 354.4 | CC(=CCC1=C(C=C(C(=C1O)C(=O)C=CC2=CC=C(C=C2)O)OC)O)C |
| EOS-AX4114 | FK 866 hydrochloride | | C24H29N3O2.HCl | 427.97 | O=C(N1CCC(CCCCNC(/C=C\C2=CN=CC=C2)=O)CC1)C3=CC=CC=C3.Cl |
| EOS-AX4115 | (±)-Bay K 8644 | 71145-03-4 | C16H15F3N2O4 | 356.3 | CC1=C(C(C(=C(N1)C)[N+](=O)[O-])C2=CC=CC=C2C(F)(F)F)C(=O)OC |
| EOS-AX4116 | Concanamycin A | 80890-47-7 | C46H75NO14 | 866.09 | CCC1C(C(CC(=CC=CC(C(OC(=O)C(=CC(=CC(C1O)C)C)OC)C(C)C(C(C)C2(CC(C(C(O2)C=CC)C)OC3CC(C(C(O3)C)OC(=O)N)O)O)O)OC)C)C)O |
| EOS-AX4117 | WEHI-539 hydrochloride | | C31H30ClN5O3S2 | 620.18 | O=C(C1=C(C([H])([H])C([H])([H])C([H])([H])OC2=C([H])C([H])=C(C([H])([H])N([H])[H])C([H])=C2[H])SC(C3=C([H])C4=C(C([H])=C3[H])C([H])([H])C([H])([H])C([H])([H])/C4=N\N([H])C5=NC6=C([H])C([H])=C([H])C([H])=C6S5)=N1)O[H] |
| EOS-AX4118 | QL47 | 1469988-75-7 | C27H21N5O2 | 447.49 | CN(N=C1)C=C1C2=CC=C(N=CC(C=C3)=C4N(C5=CC(N(C(C=C)=O)CC6)=C6C=C5)C3=O)C4=C2 |
| EOS-AX4119 | RN486 | 1242156-23-5 | C35H35FN6O3 | 606.69 | CN1CCN(CC1)C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=CC=C4)N5C=CC6=CC(=CC(=C6C5=O)F)C7CC7)CO |
| EOS-AX4120 | IOWH-032 | 1191252-49-9 | C22H15Br2N3O4 | 545.18 | C1=CC=C(C=C1)OC2=CC=C(C=C2)CNC(=O)C3=NC(=C4C=C(C(=O)C(=C4)Br)Br)NO3 |
| EOS-AX4121 | LY2603618 | 911222-45-2 | C18H22BrN5O3 | 436.3 | CC1=CC(=C(C=C1Br)NC(=O)NC2=NC=C(N=C2)C)OCC3CNCCO3 |
| EOS-AX4122 | Deferasirox | 201530-41-8 | C21H15N3O4 | 373.36 | C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1 |
| EOS-AX4123 | Flavopiridol hydrochloride | 131740-09-5 | C21H21Cl2NO5 | 438.3 | CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O.Cl |
| EOS-AX4124 | LEE011 | 1211441-98-3 | C23H30N8O | 434.54 | CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5 |
| EOS-AX4125 | R547 | 741713-40-6 | C18H21F2N5O4S | 441.45 | COC1=C(C(=C(C=C1)F)F)C(=O)C2=CN=C(N=C2N)NC3CCN(CC3)S(=O)(=O)C |
| EOS-AX4126 | WHI-P180 | 211555-08-7 | C16H15N3O3 | 297.31 | COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)O)OC |
| EOS-AX4127 | Acyclovir | 59277-89-3 | C8H11N5O3 | 225.21 | C1=NC2=C(N1COCCO)NC(=NC2=O)N |
| EOS-AX4128 | Viomycin | 32988-50-4 | C25H43N13O10.2H2SO4 | 881.85 | C1C(NC(=NC1O)N)C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CO)CO)NC(=O)CC(CCCN)N |
| EOS-AX4129 | Trovafloxacin mesylate | 147059-75-4 | C20H15F3N4O3.CH3SO3H | 512.46 | CS(=O)(=O)O.C1C2C(C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F |
| EOS-AX4130 | Capecitabine | 154361-50-9 | C15H22FN3O6 | 359.35 | CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O |
| EOS-AX4131 | Oxaliplatin | 61825-94-3 | C8H14N2O4Pt | 397.29 | C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2] |
| EOS-AX4132 | NU 7026 | 154447-35-5 | C17H15NO3 | 281.31 | C1COCCN1C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3 |
| EOS-AX4133 | Saxagliptin | 361442-04-8 | C18H25N3O2 | 315.41 | C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N |
| EOS-AX4134 | LY2940680 | 1258861-20-9 | C26H24F4N6O | 512.5 | CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F |
| EOS-AX4135 | JK 184 | 315703-52-7 | C19H18N4OS | 350.44 | CCOC1=CC=C(C=C1)NC2=NC(=CS2)C3=C(N=C4N3C=CC=C4)C |
| EOS-AX4136 | SANT-2 | 329196-48-7 | C26H26ClN3O4 | 479.96 | CCOC1=CC(=CC(=C1OCC)OCC)C(=O)NC2=CC(=C(C=C2)Cl)C3=NC4=CC=CC=C4N3 |
| EOS-AX4137 | HPI 1 | 599150-20-6 | C27H29NO6 | 463.52 | CC1=C(C(C2=C(N1)CC(CC2=O)C3=CC=CC=C3OC)C4=CC(=CC=C4)O)C(=O)OCCOC |
| EOS-AX4138 | Ciliobrevin A | 302803-72-1 | C17H9Cl2N3O2 | 358.18 | C1=CC=C2C(=C1)C(=O)NC(=C(C#N)C(=O)C3=C(C=C(C=C3)Cl)Cl)N2 |
| EOS-AX4139 | Jervine | 469-59-0 | C27H39NO3 | 425.6 | CC1CC2C(C(C3(O2)CCC4C5CC=C6CC(CCC6(C5C(=O)C4=C3C)C)O)C)NC1 |
| EOS-AX4140 | AZ 12080282 dihydrochloride | | C23H20N4O2.2HCl | 457.35 | CC1=C(NC(C2=CC=C(OCC3=NC=CC=C3)C=C2)=O)C=C(C4=NC=CN4)C=C1.Cl.Cl |
| EOS-AX4141 | AY 9944 dihydrochloride | 366-93-8 | C22H28Cl2N2.2HCl | 464.3 | C1CC(CCC1CNCC2=CC=CC=C2Cl)CNCC3=CC=CC=C3Cl.Cl.Cl |
| EOS-AX4142 | SANT-1 | 304909-07-7 | C23H27N5 | 373.5 | CC1=C(C(=NN1C2=CC=CC=C2)C)C=NN3CCN(CC3)CC4=CC=CC=C4 |
| EOS-AX4143 | Cilengitide | 188968-51-6 | C27H40N8O7 | 588.66 | CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N |
| EOS-AX4144 | MNS | 1485-00-3 | C9H7NO4 | 193.16 | C1OC2=C(O1)C=C(C=C2)C=C[N+](=O)[O-] |
| EOS-AX4145 | A 205804 | 251992-66-2 | C15H12N2OS2 | 300.39 | CC1=CC=C(C=C1)SC2=C3C=C(SC3=CN=C2)C(=O)N |
| EOS-AX4146 | BIO 1211 | 187735-94-0 | C36H48N6O9 | 708.8 | CC1=CC=CC=C1NC(=O)NC2=CC=C(C=C2)CC(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)N3CCCC3C(=O)O |
| EOS-AX4147 | A 286982 | 280749-17-9 | C24H27N3O4S | 453.55 | CC(C)C1=CC=CC=C1SC2=C(C=C(C=C2)C=CC(=O)N3CCN(CC3)C(=O)C)[N+](=O)[O-] |
| EOS-AX4148 | SLIGRL-NH2 | 171436-38-7 | C29H56N10O7 | 656.82 | CCC(C)C(C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CO)N |
| EOS-AX4149 | TFLLR-NH2 | 197794-83-5 | C31H53N9O6 | 647.82 | CC(C[C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])[C@@](O)([H])C)([H])CC1=CC=CC=C1)([H])CC(C)C)([H])/C(O)=N/[C@@](C(O)=N)([H])CCCNC(N)=N)C |
| EOS-AX4150 | AY-NH2 | 352017-71-1 | C34H48N8O7 | 680.8 | C[C@@](N)([H])/C(O)=N/[C@@](C(N1CCC[C@@]1([H])/C(O)=N/C/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=N)([H])CC2=CC=CC=C2)([H])CCCCN)=O)([H])CC3=CC=C(O)C=C3 |
| EOS-AX4151 | Thrombin Receptor Agonist Peptide | 137339-65-2 | C81H118N20O23 | 1739 | CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCC(=O)O)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CO)N |
| EOS-AX4152 | AC 55541 | 916170-19-9 | C25H20BrN5O3 | 518.36 | O=C1C2=CC=CC=C2C(C(NC(C3=CC=CC=C3)=O)C(N/N=C(C)/C4=CC=CC(Br)=C4)=O)=NN1 |
| EOS-AX4153 | AC 264613 | 1051487-82-1 | C19H18BrN3O2 | 400.27 | CC(=NNC(=O)C1C(CNC1=O)C2=CC=CC=C2)C3=CC(=CC=C3)Br |
| EOS-AX4154 | VKGILS-NH2 | 942413-05-0 | C28H54N8O7 | 614.79 | CC[C@]([C@@](/N=C(O)/C/N=C(O)/[C@](/N=C(O)/[C@](N)([H])C(C)C)([H])CCCCN)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=N)([H])CO)([H])CC(C)C)([H])C |
| EOS-AX4155 | RLLFT-NH2 | 447408-68-6 | C31H53N9O6 | 647.82 | CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)N)NC(=O)C(CCCN=C(N)N)N |
| EOS-AX4156 | LRGILS-NH2 | 245329-01-5 | C29H56N10O7 | 656.83 | CC[C@]([C@@](/N=C(O)/C/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CC(C)C)([H])CCCNC(N)=N)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=N)([H])CO)([H])CC(C)C)([H])C |
| EOS-AX4157 | PAR 4 (1-6) | 225779-44-2 | C28H41N7O9 | 619.68 | CC([C@@](/N=C(O)/[C@](/N=C(O)/C/N=C(O)/[C@]1([H])CCCN1C([C@](/N=C(O)/CN)([H])CC2=CC=C(O)C=C2)=O)([H])CCC(O)=N)([H])C(O)=O)C |
| EOS-AX4158 | TRAP-6 | 141136-83-6 | C34H56N10O9 | 748.88 | CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)N |
| EOS-AX4159 | 2-Furoyl-LIGRLO-amide | 729589-58-6 | C36H63N11O8 | 777.96 | CC[C@]([C@@](/N=C(O)/[C@](NC(C1=CC=CO1)=O)([H])CC(C)C)([H])/C(O)=N/C/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=N)([H])CCCN)([H])CC(C)C)([H])CCCNC(N)=N)([H])C |
| EOS-AX4160 | SLIGKV-NH2 | 190383-13-2 | C28H54N8O7 | 614.78 | CCC(C)C(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CO)N |
| EOS-AX4161 | CID 755673 | 521937-07-5 | C12H11NO3 | 217.22 | C1CC2=C(C(=O)NC1)OC3=C2C=C(C=C3)O |
| EOS-AX4162 | CRT 0066101 | | C18H22N6O.3HCl | 447.79 | CN1N=CC(C2=CC(C3=NC(NC[C@H](N)CC)=CC=N3)=C(O)C=C2)=C1.Cl.Cl.Cl |
| EOS-AX4163 | MLN0905 | 1228960-69-7 | C24H25F3N6S | 486.56 | CC1=C(C=C(C=N1)CCCN(C)C)NC2=NC=C3CC(=S)NC4=C(C3=N2)C=CC(=C4)C(F)(F)F |
| EOS-AX4164 | Ro3280 | 1062243-51-9 | C27H35F2N7O3 | 543.61 | CN1CCC(CC1)NC(=O)C2=CC(=C(C=C2)NC3=NC=C4C(=N3)N(CC(C(=O)N4C)(F)F)C5CCCC5)OC |
| EOS-AX4165 | NVP-BHG712 | 940310-85-0 | C26H20F3N7O | 503.48 | CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)NC3=NC(=NC4=C3C=NN4C)C5=CN=CC=C5 |
| EOS-AX4166 | ZM 306416 | 690206-97-4 | C16H13ClFN3O2 | 333.74 | COC1=C(C=C2C(=C1)C(=NC=N2)NC3=C(C=C(C=C3)Cl)F)OC |
| EOS-AX4167 | Wnt-C59 | 1243243-89-1 | C25H21N3O | 379.45 | CC1=NC=CC(=C1)C2=CC=C(C=C2)CC(=O)NC3=CC=C(C=C3)C4=CN=CC=C4 |
| EOS-AX4168 | VX-745 | 209410-46-8 | C19H9Cl2F2N3OS | 436.27 | C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl |
| EOS-AX4169 | VX-702 | 479543-46-9 | C19H12F4N4O2 | 404.33 | C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F |
| EOS-AX4170 | TAK-715 | 303162-79-0 | C24H21N3OS | 399.52 | CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC(=CC=C4)C |
| EOS-AX4171 | PD 169316 | 152121-53-4 | C20H13FN4O2 | 360.34 | C1=CC(=CC=C1C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)[N+](=O)[O-] |
| EOS-AX4172 | Flumatinib mesylate | 895519-91-2 | C30H33F3N8O4S | 658.69 | CC1=C(C=C(C=N1)NC(=O)C2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O |
| EOS-AX4173 | PF-431396 | 717906-29-1 | C22H21F3N6O3S | 506.5 | CN(C1=CC=CC=C1CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C |
| EOS-AX4174 | C527 | 192718-06-2 | C17H8FNO3 | 293.25 | O=C1C2=C(N=C(C3=CC=C(F)C=C3)O2)C(C4=CC=CC=C41)=O |
| EOS-AX4175 | AI-10-49 | 1256094-72-0 | C30H22F6N6O5 | 660.52 | FC(F)(F)OC1=CC2=C(C=C1)NC(C(C=C3)=NC=C3OCCOCCOC(C=C4)=CN=C4C5=NC6=CC(OC(F)(F)F)=CC=C6N5)=N2 |
| EOS-AX4176 | KC02 | | C22H41NO3 | 367.57 | CCCCCCCCCCCCCC1OC(C1CCCCCC(N)=O)=O |
| EOS-AX4177 | FIIN-2 | 1633044-56-0 | C35H38N8O4 | 634.73 | O=C(C=C)NC1=CC=C(CN2C(N(C3=CC(OC)=CC(OC)=C3)CC4=CN=C(NC5=CC=C(N6CCN(C)CC6)C=C5)N=C42)=O)C=C1 |
| EOS-AX4178 | FIIN-3 | | C34H36Cl2N8O4 | 691.61 | O=C(C=C)NC1=CC=C(CN(C2=CC(NC3=CC=C(N4CCN(C)CC4)C=C3)=NC=N2)C(NC5=C(Cl)C(OC)=CC(OC)=C5Cl)=O)C=C1 |
| EOS-AX4179 | SP-2509 | 1423715-09-6 | | | |
| EOS-AX4180 | DZ-1 (Z) | | | | |
| EOS-AX4181 | Mesoridazine Besylate | 32672-69-8 | C27H32N2O4S3 | 544.75 | O=S(C)C1=CC=C2SC3=CC=CC=C3N(C2=C1)CC[C@H]4N(C)CCCC4.OS(=O)(C5=CC=CC=C5)=O |
| EOS-AX4182 | Mesoridazine | 5588-33-0 | C21H26N2OS2 | 386.57 | CN1CCCCC1CCN2C3=C(C=CC(S(C)=O)=C3)SC4=C2C=CC=C4 |
| EOS-AX4183 | Isosafrole | 120-58-1 | C10H10O2 | 162.19 | C/C=C/C1=CC=C2C(OCO2)=C1 |
| EOS-AX4184 | Stiripentol | 49763-96-4 | C14H18O3 | 234.29 | OC(C(C)(C)C)/C=C/C1=CC2=C(OCO2)C=C1 |
| EOS-AX4185 | SCR7 | 1533426-72-0 | C18H14N4OS | 334.39 | S=C(NC(/N=C/C1=CC=CC=C1)=C2/N=C/C3=CC=CC=C3)NC2=O |
| EOS-AX4186 | BLU9931 | 1538604-68-0 | C26H22Cl2N4O3 | 509.38 | ClC1=C(C2=CC(C=NC(NC(C(NC(C=C)=O)=CC=C3)=C3C)=N4)=C4C=C2)C(Cl)=C(OC)C=C1OC |
| EOS-AX4187 | Nec-29 | 60059-55-4 | C15H14N4O2 | 282.3 | |
| EOS-AX4188 | Sephin1 | 13098-73-2 | C8H9ClN4 | 196.64 | ClC1=CC=CC=C1/C=N/NC(N)=N |
| EOS-AX4189 | SW033291 | 459147-39-8 | C21H20N2OS3 | 412.59 | NC1=C(S(CCCC)=O)SC2=NC(C3=CC=CS3)=CC(C4=CC=CC=C4)=C21 |
| EOS-AX4190 | ETC-1002 | | C19H36O5 | 344.49 | OC(C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(O)=O)=O |
| EOS-AX4191 | DDD107498 | | C27H31FN4O2 | 462.56 | O=C(NCCN1CCCC1)C2=CC(C3=CC=C(CN4CCOCC4)C=C3)=NC5=CC=C(F)C=C52 |
| EOS-AX4192 | MCB-613 | 1162656-22-5 | C19H19N3O | 305.37 | O=C(/C(CN(CC)C/1)=C/C2=CC=CN=C2)C1=C\C3=CN=CC=C3 |
| EOS-AX4193 | Boc-Lys(Ac)-AMC | 233691-67-3 | C23H31N3O6 | 445.51 | CC(C)(C)OC(N[C@H](C(NC(C=C1)=CC(O2)=C1C(C)=CC2=O)=O)CCCCNC(C)=O)=O |
| EOS-AX4194 | SR-9243 | 1613028-81-1 | C31H32BrNO4S2 | 626.62 | CC(C=C(C)C=C1C)=C1S(N(CC2=CC=C(C3=CC(C)=CC=C3)C=C2)CCC4=CC=CC(Br)=C4)(=O)=O.O=S=O |
| EOS-AX4195 | SBI-0206965 | 1884220-36-3 | C21H21BrN4O5 | 489.32 | C/N=C(O)/C1=CC=CC=C1OC2=NC(NC3=CC(OC)=C(OC)C(OC)=C3)=NC=C2Br |
| EOS-AX4196 | LY3009120 | 1454682-72-4 | C23H29FN6O | 424.51 | CC1=NC2=NC(NC)=NC=C2C=C1C3=CC(NC(NCCC(C)(C)C)=O)=C(F)C=C3C |
| EOS-AX4197 | THZ2 | 1604810-84-5 | C31H28ClN7O2 | 566.05 | CN(C/C([H])=C([H])/C(O)=N/C1=CC=CC(/C(O)=N/C2=CC(NC3=NC=C(Cl)C(C4=CNC5=CC=CC=C45)=N3)=CC=C2)=C1)C |
| EOS-AX4198 | GX-674 | | C21H13ClF2N6O3S2 | 534.95 | ClC1=CC(C2=CC(N=C(N)N3)=C3C=C2)=C(OC4=C(F)C=C(S(NC5=NC=NS5)(=O)=O)C(F)=C4)C=C1 |
| EOS-AX4199 | ML 239 | 1378872-36-6 | C13H10Cl3N3O2 | 346.6 | ClC1=CC(Cl)=C(OC/C(O)=N/N=C([H])/C2=CC=CN2)C(Cl)=C1 |
| EOS-AX4200 | MYK-461 | | C15H19N3O2 | 273.33 | C[C@H](NC(NC(N1C(C)C)=O)=CC1=O)C2=CC=CC=C2 |
| EOS-AX4201 | CBR-5884 | | C14H12N2O4S2 | 336.39 | O=C(NC1=C(SC#N)C(C)=C(C(OCC)=O)S1)C2=CC=CO2 |
| EOS-AX4202 | CHMFL-ABL-053 | 1808287-83-3 | C28H26F3N7O2 | 549.55 | CC1=CC=C(NC2=NC(NC)=C(C(NC3=CC(NC(C4=CC=CC(C(F)(F)F)=C4)=O)=CC=C3C)=O)C=N2)C=C1N |
| EOS-AX4203 | GSK180 | | C10H7Cl2NO4 | 276.07 | ClC1=C(Cl)C=C2C(N(CCC(O)=O)C(O2)=O)=C1 |
| EOS-AX4204 | ONC201 | 1616632-77-9 | C24H26N4O | 386.49 | CC1=CC=CC=C1CN(C2=NCCN32)C(C(C4)=C3CCN4CC5=CC=CC=C5)=O |
| EOS-AX4205 | UNC3866 | | C43H66N6O8 | 795.02 | CC(C)(C)C1=CC=C(C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCCN(CC)CC)C(N[C@@H](CO)C(OC)=O)=O)=O)=O)=O)=O)C=C1 |
| EOS-AX4206 | Senexin B | 1449228-40-3 | C27H26N6O | 450.53 | CN(CC1)CCN1C(C2=CC3=CC=C(C=C3C=C2)CCNC4=C(C=C(C#N)C=C5)C5=NC=N4)=O |
| EOS-AX4207 | XMU-MP-1 | | C17H16N6O3S2 | 416.48 | O=S(C1=CC=C(NC2=NC=C3C(N(C)C(C=CS4)=C4C(N3C)=O)=N2)C=C1)(N)=O |
| EOS-AX4208 | THZ531 | | C30H32ClN7O2 | 558.07 | ClC1=CN=C(N[C@H]2CN(C(C3=CC=C(NC(/C=C/CN(C)C)=O)C=C3)=O)CCC2)N=C1C4=CNC5=C4C=CC=C5 |
| EOS-AX4209 | S63845 | 1799633-27-4 | C39H37ClF4N6O6S | 829.26 | OC([C@@H](OC1=NC=NC2=C1C(C3=C(C)C(Cl)=C(OCCN4CCN(C)CC4)C=C3)=C(C5=CC=C(F)O5)S2)CC6=CC=CC=C6OCC7=CC=NN7CC(F)(F)F)=O |
| EOS-AX4210 | TASIN-1 | | C18H28N2O3S | 352.49 | CC1CCN(C2CCN(S(C3=CC=C(OC)C=C3)(=O)=O)CC2)CC1 |
| EOS-AX4211 | CCT251545 analogue, Compound 51 | | C23H22N6O2 | 414.46 | NC1=C2C(N=C(C(N3CC(OC)C3)=O)C=C2)=C(C4=CC=C(C5=CN(C)N=C5)C=C4)C=N1 |
| EOS-AX4212 | C598-0466 | | C23H32ClN3O | 401.97 | O=C(C(C=CC1=C2Cl)=CC1=NC3=C2CCCC3)NCCCN(CCC)CCC |
| EOS-AX4213 | Coumarin Thioester | | C23H24N2O4S | 424.51 | CCN(C1=CC=C(C=C(C(NCC(SCC2=CC=CC=C2)=O)=O)C(O3)=O)C3=C1)CC |
| EOS-AX4214 | SYBR Safe DNA Gel Stain | | C28H28N2O3S2 | 504.66 | CCC[N+]1=CC=C(/C=C2SC3=CC=CC=C3N\2C)C4=CC=CC=C14.O=S(C5=CC=C(C)C=C5)([O-])=O |
| EOS-AX4215 | CM-272 | | C28H38N4O3 | 478.63 | COC1=C(C=C(N=C(C2=CC=C(C)O2)C=C3NC4CCN(C)CC4)C3=C1)OCCCN5CCCC5 |
| EOS-AX4216 | ICP 103 | | C24H16N4O2 | 392.41 | O=C(C1=C2C3=C(C4=C1C5=CC=CC=C5N4C)N(CCC#N)C6=C3C=CC=C6)NC2=O |
| EOS-AX4217 | (S)-Crizotinib | 877399-52-5 | C21H22Cl2FN5O | 450.34 | CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
| EOS-AX4218 | RGFP966 | 1357389-11-7 | C21H19FN4O | 362.4 | C1=CC=C(C=C1)C=CCN2C=C(C=N2)C=CC(=O)NC3=C(C=C(C=C3)F)N |
| EOS-AX4219 | AMG232 | 1352066-68-2 | C28H35Cl2NO5S | 568.55 | CC(S(C[C@@H](N([C@H](C1=CC=C(Cl)C=C1)[C@@H](C2=CC=CC(Cl)=C2)C[C@]3(C)CC(O)=O)C3=O)C(C)C)(=O)=O)C |
| EOS-AX4220 | TMP269 | 1314890-29-3 | C25H21F3N4O3S | 514.52 | FC(F)(F)C1=NC(C2=CC(/C(O)=N/CC3(C4=NC(C5=CC=CC=C5)=CS4)CCOCC3)=CC=C2)=NO1 |
| EOS-AX4221 | MK-8745 | 885325-71-3 | C20H19ClFN5OS | 431.91 | ClC1=C(F)C(C(N2CCN(CC3=NC(NC4=NC=CS4)=CC=C3)CC2)=O)=CC=C1 |
| EOS-AX4222 | ME0328 | 1445251-22-8 | C19H19N3O2 | 321.37 | CC(C1=CC=CC=C1)NC(=O)CCC2=NC(=O)C3=CC=CC=C3N2 |
| EOS-AX4223 | Vorapaxar | 618385-01-6 | C29H33FN2O4 | 492.58 | CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C |
| EOS-AX4224 | UNC669 | 1314241-44-5 | C15H20BrN3O | 338.24 | C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=CN=C3)Br |
| EOS-AX4225 | PF-04880594 | 1111636-35-1 | C19H16F2N8 | 394.38 | C1=CNC2=NC=C(C=C21)C3=NN(C=C3C4=NC(=NC=C4)NCCC#N)CC(F)F |
| EOS-AX4226 | PD173955 | 260415-63-2 | C21H16Cl2N4OS | 443.35 | CN1C2=NC(=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl)NC4=CC(=CC=C4)SC |
| EOS-AX4227 | NSC697923 | 343351-67-7 | C11H9NO5S | 267.26 | CC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(O2)[N+](=O)[O-] |
| EOS-AX4228 | NH125 | 278603-08-0 | C27H45IN2 | 524.56 | CCCCCCCCCCCCCCCCN1C=C[N+](=C1C)CC2=CC=CC=C2.[I-] |
| EOS-AX4229 | SM-164 | 957135-43-2 | C62H84N14O6 | 1121.42 | O=C([C@H]1N(C([C@@H](NC([C@H](C)NC)=O)CCCC2)=O)[C@]2([H])CC1)N[C@H](C3=CN(CCCCC4=CC=C(CCCCN5C=C([C@H](NC([C@@H]6CC[C@](CCCC[C@@H]7NC([C@@H](NC)C)=O)([H])N6C7=O)=O)C8=CC=CC=C8)N=N5)C=C4)N=N3)C9=CC=CC=C9 |
| EOS-AX4230 | ZIP (SCRAMBLED) | 908012-18-0 | C90H154N30O17 | 1928.4 | |
| EOS-AX4231 | N-(5-aminopentyl)-N-hydroxyacetamide | | | | |
| EOS-AX4232 | WZ3146 | 1214265-56-1 | C24H25ClN6O2 | 464.95 | C=CC(NC1=CC=CC(OC2=NC(NC3=CC=C(N4CCN(C)CC4)C=C3)=NC=C2Cl)=C1)=O |
| EOS-AX4233 | THZ1 | 1604810-83-4 | C31H28ClN7O2 | 566.05 | ClC1=CN=C(N=C1C2=CNC3=CC=CC=C23)NC4=CC=CC(NC(C5=CC=C(NC(/C=C/CN(C)C)=O)C=C5)=O)=C4 |
| EOS-AX4234 | SAR405 | 1523406-39-4 | C19H21ClF3N5O2 | 443.85 | C[C@H]1N(C(N=C2N3CC[C@@H](C(F)(F)F)N2CC4=CN=CC(Cl)=C4)=CC3=O)CCOC1 |
| EOS-AX4235 | KC01 | | C22H39NO3 | 365.55 | CCCCCCCCCCCCCC1OC(/C1=C\CCCCC(N)=O)=O |
| EOS-AX4236 | Ro 3306 | 872573-93-8 | C18H13N3OS2 | 351.45 | O=C1N=C(NCC2=CC=CS2)S/C1=C\C3=CC=C(N=CC=C4)C4=C3 |
| EOS-AX4237 | UNBS 5162 | 956590-23-1 | C17H18N4O3 | 326.35 | CN(C)CCN1C(C2=C3C(C=CC=C3C1=O)=CC(NC(N)=O)=C2)=O |
| EOS-AX4238 | G-749 | 1457983-28-6 | C25H25BrN6O2 | 521.41 | O=C1NC=C(Br)C2=C1C(NC3=CC=C(OC4=CC=CC=C4)C=C3)=NC(NC5CCN(C)CC5)=N2 |
| EOS-AX4239 | HTH-01-015 | 1613724-42-7 | C26H28N8O | 468.55 | CN1C(C2=CC3=CC=CC=C3C=C2N(C)C4=NC(NC5=CN(C6CCNCC6)N=C5)=NC(C)=C14)=O |
| EOS-AX4240 | WWL 70 | 947669-91-2 | C27H23N3O3 | 437.49 | O=C(N(C)CC1=CC=CC(C2=CC=NC=C2)=C1)OC3=CC=C(C=C3)C4=CC=C(C(N)=O)C=C4 |
| EOS-AX4241 | Rucaparib (free base) | 283173-50-2 | C19H18FN3O | 323.36 | FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1 |
| EOS-AX4242 | p-Cresyl sulfate | 3233-58-7 | C7H8O4S | 188.2 | CC1=CC=C(OS(O)(=O)=O)C=C1 |
| EOS-AX4243 | (+)-MK 801 Maleate | 77086-22-7 | C20H19NO4 | 337.37 | C[C@]1(N2)C3=C(C=CC=C3)C[C@@H]2C4=C1C=CC=C4.O=C(O)/C=C\C(O)=O |
| EOS-AX4244 | | | | | |
| EOS-AX4245 | HZ-1157 | 1009734-33-1 | C12H16N4O | 232.28 | NC1=NC(N)=NC2=CC=CC(OC(C)(C)C)=C21 |
| EOS-AX4246 | EVOTEC定制 | | | | |
| EOS-AX4247 | (3S,4S)-3-(Boc-amino)-4-methylpyrrolidine | 127199-54-6 | C10H20N2O2 | 200.28 | C[C@H]1CNC[C@H]1NC(=O)OC(C)(C)C |
| EOS-AX4248 | Nanaomycin C | 58286-55-8 | C16H15NO5 | 301.294 | CC1C2=C(CC(O1)CC(=O)N)C(=O)C3=C(C2=O)C(=CC=C3)O |
| EOS-AX4249 | 6H05 | | C22H31ClF3N3O4S3 | 590.14 | ClC1=CC=C(SCC(N2CCC(C(NCCSSCCN(C)C)=O)CC2)=O)C=C1.OC(C(F)(F)F)=O |
| EOS-AX4250 | (R)-2-Methylcysteine HCl | 148766-37-4 | C4H9NO2S•HCl | 171.65 | CC(CS)(C(=O)O)N.Cl |
| EOS-AX4251 | UM 171 | 1448724-09-1 | C25H27N9 | 453.54 | N[C@@H](CC1)CC[C@H]1NC2=NC(CC3=CC=CC=C3)=NC(N4)=C2C5=C4C=C(C6=NN(C)N=N6)C=C5 |
| EOS-AX4252 | UM 191 | | | | |
| EOS-AX4253 | UM 729 | 1448723-60-1 | C20H25N5O2 | 367.44 | O=C(OC)C1=CC=C(C2=C(NCCCN3CCCCC3)N=CN=C2N4)C4=C1 |
| EOS-AX4254 | MK 6096 | 1088991-73-4 | C24H25FN4O2 | 420.48 | CC1=CC=C(C2=NC=CC=N2)C(C(N3C[C@@H](COC4=NC=C(F)C=C4)CC[C@@H]3C)=O)=C1 |
| EOS-AX4255 | Ac-YVAD-CHO | 143313-51-3 | C23H32N4O8 | 492.5 | CC(N([C@H](C(N([C@H](C(N([C@H](C(N([C@H](C([H])=O)CC(O)=O)[H])=O)C)[H])=O)C(C)C)[H])=O)CC1=CC=C(C=C1)O)[H])=O |
| EOS-AX4256 | Z-YVAD-FMK | | C31H39FN4O9 | 630.66 | COC(C[C@H](NC([C@H](C)NC([C@@H](NC(C(CC1=CC=C(O)C=C1)NC(OCC2=CC=CC=C2)=O)=O)C(C)C)=O)=O)C(CF)=O)=O |
| EOS-AX4257 | Ac-YVAD-AFC | 219137-85-6 | C33H36F3N5O10 | 719.66 | CC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NC1=CC(OC(C=C2C(F)(F)F)=O)=C2C=C1)=O)CC(O)=O)=O)C)=O)C(C)C)=O)CC3=CC=C(O)C=C3)=O |
| EOS-AX4258 | AUDA | 479413-70-2 | C23H40N2O3 | 392.58 | O=C(N([H])CCCCCCCCCCCC(O)=O)N([H])C1(C2)C[C@@H](C[C@@H]2C3)C[C@@H]3C1 |
| EOS-AX4259 | GW841819X | | C26H22ClN5O3 | 487.94 | ClC(C=C1)=CC=C1C2=N[C@@H](NC(OCC3=CC=CC=C3)=O)C4=NN=C(C)N4C5=CC=C(OC)C=C52 |
| EOS-AX4260 | OTS514 | 1338540-55-8 | C20H18N2O2S | 350.43 | NC[C@H](C)C1=CC=C(C2=C(O)C=CC3=C2C(C=CS4)=C4C(N3)=O)C=C1 |
| EOS-AX4261 | OTS964 | 1338545-07-5 | C22H22N2O2S | 378.49 | C[C@@H](CN(C)C)C1=CC=C(C2=C(O)C=CC3=C2C(C=CS4)=C4C(N3)=O)C=C1 |
| EOS-AX4262 | BQU57 | 1637739-82-2 | C16H13F3N4O | 334.3 | CC1=NN(C)C(OC(N)=C2C#N)=C1C2C3=CC=C(C(F)(F)F)C=C3 |
| EOS-AX4263 | Caspase Inhibitor Set I | | | | |
| EOS-AX4264 | Bcl Family Set I | | | | |
| EOS-AX4265 | p53/MDM2 Set I | | | | |
| EOS-AX4266 | AKT/mTOR Set I | | | | |
| EOS-AX4267 | Stem Cell Set I | | | | |
| EOS-AX4268 | HDAC Set I | | | | |
| EOS-AX4269 | MEK Inhibitor Set | | | | |
| EOS-AX4270 | Chk1 and MK2 Inhibitors set | | | | |
| EOS-AX4271 | | | | | |
| EOS-AX4272 | Loxapine | 1977-10-2 | C18H18ClN3O | 327.81 | CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl |
| EOS-AX4273 | Tropisetron Hydrochloride | 105826-92-4 | C17H21ClN2O2 | 320.81 | CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43.Cl |
| EOS-AX4274 | Mc-Val-Cit-PABC-PNP | 159857-81-5 | C35H43N7O11 | 737.76 | CC([C@@](/N=C(O)/CCCCCN1C(C=CC1=O)=O)([H])/C(O)=N/[C@@](C(NC2=CC=C(COC(OC3=CC=C(N(=O)=O)C=C3)=O)C=C2)=O)([H])CCCNC(O)=N)C |
| EOS-AX4275 | ICI 118,551 hydrochloride | 72795-01-8 | C17H28ClNO2 | 313.86 | CC1=C2CCCC2=C(C=C1)OCC(C(C)NC(C)C)O.Cl |
| EOS-AX4276 | Vilanterol | 503068-34-6 | C24H33Cl2NO5 | 486.43 | C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl |
| EOS-AX4277 | Vilanterol trifenatate | 503070-58-4 | C44H49Cl2NO7 | 774.77 | C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl |
| EOS-AX4278 | AVE 0991 | 304462-19-9 | C29H32N4O5S2 | 580.72 | CCNC(=O)NS(=O)(=O)C1=C(C=C(S1)CC(C)C)C2=CC=C(C=C2)CN3C(=C(N=C3C4=CC=CC=C4)OC)C=O |
| EOS-AX4279 | Tilbroquinol | 7175-09-9 | C10H8BrNO | 238.08 | CC1=CC(=C(C2=C1C=CC=N2)O)Br |
| EOS-AX4280 | Arginase inhibitor 1 | 1345808-25-4 | C13H27BN2O4 | 286.18 | N[C@](CCN1CCCCC1)(C(O)=O)CCCCB(O)O |
| EOS-AX4281 | Frentizole | 26130-02-9 | C15H13N3O2S | 299.35 | COC1=CC2=C(C=C1)N=C(S2)NC(=O)NC3=CC=CC=C3 |
| EOS-AX4282 | Bafetinib (INNO-406) | 887650-05-7 | C30H31F3N8O | 576.62 | CC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CCC(C3)N(C)C)C(F)(F)F)NC4=NC=C(C=N4)C5=CN=CN=C5 |
| EOS-AX4283 | MS436 | 1395084-25-9 | C18H17N5O3S | 383.42 | CC1=CC(=NNC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3)C(=CC1=O)N |
| EOS-AX4284 | GSK1324726A | 1300031-52-0 | C25H23ClN2O3 | 434.91 | OC(C(C=C1)=CC=C1C2=CC3=C(C=C2)N(C(C)=O)[C@@H](C)C[C@H]3NC4=CC=C(Cl)C=C4)=O |
| EOS-AX4285 | XL413 hydrochloride | 1169562-71-3 | C14H13Cl2N3O2 | 326.18 | C1CC(NC1)C2=NC(=O)C3=C(N2)C4=C(O3)C=CC(=C4)Cl.Cl |
| EOS-AX4286 | MK-8033 hydrochloride | 1283000-43-0 | C25H22ClN5O3S | 507.99 | CN1C=C(C(C=N2)=CC3=C2C=CC4=C(C3=O)C=C(CS(NCC5=CC=CC=N5)(=O)=O)C=C4)C=N1.Cl |
| EOS-AX4287 | Parecoxib | 198470-84-7 | C19H18N2O4S | 370.42 | CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C |
| EOS-AX4288 | (S)-(+)-Ibuprofen | 51146-56-6 | C13H18O2 | 206.28 | CC(C)CC1=CC=C(C=C1)C(C)C(=O)O |
| EOS-AX4289 | Afatinib | | | | |
| EOS-AX4290 | AST-1306 TsOH | 1050500-29-2 | C31H26ClFN4O5S | 621.08 | CC1=CC=C(C=C1)S(=O)(=O)O.C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl |
| EOS-AX4291 | EI1 | 1418308-27-6 | C23H26N4O2 | 390.48 | CCC(CC)N1C=CC2=C(C=C(C=C21)C#N)C(=O)NCC3=C(C=C(NC3=O)C)C |
| EOS-AX4292 | BIBF 1120 | 656247-17-5 | C31H33N5O4 | 539.62 | |
| EOS-AX4293 | Pacritinib | | | | |
| EOS-AX4294 | AWD 131-138 | 188116-07-6 | C13H14ClN3O2 | 279.72 | C1COCCN1C2=NC(=O)N(C2)C3=CC=C(C=C3)Cl |
| EOS-AX4295 | Ledipasvir acetone | 1441674-54-9 | C52H60F2N8O7 | 947.08 | CC([C@@](/N=C(OC)\O)([H])C(N1CC2(C[C@@]1([H])C3=NC=C(N3)C4=CC5=C(C6=C(C5(F)F)C=C(C7=CC(N8)=C(N=C8[C@]9([H])[C@@]%10([H])CC[C@](N9C([C@](/N=C(OC)\O)([H])C(C)C)=O)([H])C%10)C=C7)C=C6)C=C4)CC2)=O)C.CC(C)=O |
| EOS-AX4296 | Ledipasvir D-tartrate | 1502654-87-6 | C53H60F2N8O12 | 1039.09 | CC([C@@](/N=C(OC)\O)([H])C(N1CC2(C[C@@]1([H])C3=NC=C(N3)C4=CC5=C(C6=C(C5(F)F)C=C(C7=CC(N8)=C(N=C8[C@]9([H])[C@@]%10([H])CC[C@](N9C([C@](/N=C(OC)\O)([H])C(C)C)=O)([H])C%10)C=C7)C=C6)C=C4)CC2)=O)C.O[C@@](C(O)=O)([H])[C@@](O)([H])C(O)=O |
| EOS-AX4297 | 2-Deoxy-D-glucose | 154-17-6 | C6H12O5 | 164.16 | [H][C@]([C@](C1([H])[H])([H])O[H])([C@](C([H])([H])O[H])([H])OC1([H])O[H])O[H] |
| EOS-AX4298 | Ciproxifan maleate | 184025-19-2 | C20H22N2O6 | 386.4 | C1CC1C(=O)C2=CC=C(C=C2)OCCCC3=CN=CN3.C(=CC(=O)O)C(=O)O |
| EOS-AX4299 | BAY 57-1293 | 348086-71-5 | C18H18N4O3S2 | 402.49 | CC1=C(SC(=N1)N(C)C(=O)CC2=CC=C(C=C2)C3=CC=CC=N3)S(=O)(=O)N |
| EOS-AX4300 | Valacyclovir hydrochloride | 124832-27-5 | C13H21ClN6O4 | 360.8 | |
| EOS-AX4301 | (3S,4S)-Tofacitinib | 1092578-47-6 | C16H20N6O | 312.37 | CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N |
| EOS-AX4302 | VU0152100 | 409351-28-6 | C18H19N3O2S | 341.43 | CC1=CC(=NC2=C1C(=C(S2)C(=O)NCC3=CC=C(C=C3)OC)N)C |
| EOS-AX4303 | (R)-(+)-Tolterodine | 124937-51-5 | C22H31NO | 325.49 | CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2 |
| EOS-AX4304 | Refametinib R enantiomer | 923032-38-6 | C19H20F3IN2O5S | 572.34 | COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F |
| EOS-AX4305 | Dolastatin 10 | 110417-88-4 | C42H68N6O6S | 785.09 | CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C |
| EOS-AX4306 | MLN4924 | 905579-51-3 | C21H25N5O4S | 443.53 | C1CC2=CC=CC=C2C1NC3=NC=NC4=C3C=CN4C5CC(C(C5)O)COS(=O)(=O)N |
| EOS-AX4307 | Alvelestat | 848141-11-7 | C25H22F3N5O4S | 545.53 | CC(N1C2=CC=CC(C(F)(F)F)=C2)=C(C3=CC=NN3C)C=C(C1=O)C(NCC4=NC=C(S(C)(=O)=O)C=C4)=O |
| EOS-AX4308 | MDL-29951 | 130798-51-5 | C12H9Cl2NO4 | 302.11 | C1=C(C=C2C(=C1Cl)C(=C(N2)C(=O)O)CCC(=O)O)Cl |
| EOS-AX4309 | LY2334737 | 892128-60-8 | C17H25F2N3O5 | 389.39 | CCCC(CCC)C(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)(F)F |
| EOS-AX4310 | BBI608 | | | | |
| EOS-AX4311 | Adrenosterone | 382-45-6 | C19H24O3 | 300.39 | CC12CCC(=O)C=C1CCC3C2C(=O)CC4(C3CCC4=O)C |
| EOS-AX4312 | (R)-(-)-Ibuprofen | 51146-57-7 | C13H18O2 | 206.28 | CC(C)CC1=CC=C(C=C1)C(C)C(=O)O |
| EOS-AX4313 | TCS 1102 | 916141-36-1 | C27H26N4O2S | 470.59 | CN1C2=CC=CC=C2N=C1SCC(=O)N3CCCC3C(=O)NC4=CC=CC=C4C5=CC=CC=C5 |
| EOS-AX4314 | Sunitinib | 557795-19-4 | C22H27FN4O2 | 398.47 | CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C |
| EOS-AX4315 | HPGDS inhibitor 1 | 1033836-12-2 | C19H19F4N3O | 381.37 | C1CN(CCC1NC(=O)C2=CN=C(C=C2)C3=CC(=CC=C3)F)CC(F)(F)F |
| EOS-AX4316 | GDC-0032 | 1282512-48-4 | C24H28N8O2 | 460.53 | CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C |
| EOS-AX4317 | Rigosertib sodium | 592542-60-4 | C21H24NNaO8S | 473.47 | COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)[O-].[Na+] |
| EOS-AX4318 | Ulipristal acetate | 126784-99-4 | C30H37NO4 | 475.62 | CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C |
| EOS-AX4319 | Delavirdine mesylate | 147221-93-0 | C23H32N6O6S2 | 552.67 | CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C.CS(=O)(=O)O |
| EOS-AX4320 | GSK 650394 | 890842-28-1 | C25H22N2O2 | 382.45 | C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O |
| EOS-AX4321 | HG-9-91-01 | 1456858-58-4 | C32H37N7O3 | 567.68 | CC1=C(/N=C(O)/N(C2=NC=NC(NC3=CC=C(N4CCN(CC4)C)C=C3)=C2)C5=C(OC)C=C(OC)C=C5)C(C)=CC=C1 |
| EOS-AX4322 | K145 hydrochloride | 1449240-68-9 | C18H25ClN2O3S | 384.92 | CCCCOC1=CC=C(C=C1)CC/C([H])=C(S2)/C(N(C2=O)CCN)=O.Cl |
| EOS-AX4323 | Resiquimod (R-848) | 144875-48-9 | C17H22N4O2 | 314.38 | CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N |
| EOS-AX4324 | Icilin | 36945-98-9 | C16H13N3O4 | 311.29 | C1C=C(NC(=O)N1C2=CC=CC=C2O)C3=CC(=CC=C3)[N+](=O)[O-] |
| EOS-AX4325 | Calcifediol-D6 | 78782-98-6 | C27H44O2 | 406.67 | CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C |
| EOS-AX4326 | VD3-D6 | 118584-54-6 | C27H44O | 390.67 | CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C |
| EOS-AX4327 | Lasmiditan | 439239-90-4 | C19H18F3N3O2 | 377.36 | CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F |
| EOS-AX4328 | Mosapride | 112885-41-3 | C21H25ClFN3O3 | 421.89 | CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N |
| EOS-AX4329 | Detomidine | 76631-46-4 | C12H14N2 | 186.25 | CC1=C(C(=CC=C1)CC2=CN=CN2)C |
| EOS-AX4330 | Alfuzosin | 81403-80-7 | C19H27N5O4 | 389.45 | CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC |
| EOS-AX4331 | Prazosin | 19216-56-9 | C19H21N5O4 | 383.4 | COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC |
| EOS-AX4332 | Tizanidine | 51322-75-9 | C9H8ClN5S | 253.71 | C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl |
| EOS-AX4333 | L-(-)-α-Methyldopa hydrochloride | 884-39-9 | C10H14ClNO4 | 247.68 | CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N.Cl |
| EOS-AX4334 | Tolrestat | 82964-04-3 | C16H14F3NO3S | 357.35 | CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC |
| EOS-AX4335 | Dolastatin 10 trifluoroacetate | | C44H69F3N6O8S | 899.11 | CC[C@]([C@@](N(C([C@](/N=C(O)/[C@](N(C)C)([H])C(C)C)([H])C(C)C)=O)C)([H])[C@@](OC)([H])CC(N1CCC[C@@]1([H])[C@@](OC)([H])[C@@](/C(O)=N/[C@@](C2=NC=CS2)([H])CC3=CC=CC=C3)([H])C)=O)([H])C.FC(F)(C(O)=O)F |
| EOS-AX4336 | Imeglimin hydrochloride | 775351-61-6 | C6H14ClN5 | 191.66 | C[C@](N=C(N(C)C)N1)([H])NC1=N.Cl |
| EOS-AX4337 | YLF-466D | 1273323-67-3 | C29H20ClNO3 | 465.93 | ClC1=CC=C(/C(C2=CC=CC=C2)=C(C3=O)/C4=CC=CC=C4N3CC5=CC(C(O)=O)=CC=C5)C=C1 |
| EOS-AX4338 | Angiotensin II human | 4474-91-3 | C50H71N13O12 | 1046.18 | |
| EOS-AX4339 | AHU-377(Sacubitril) | 149709-62-6 | C24H29NO5 | 411.49 | CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O |
| EOS-AX4340 | Azilsartan medoxomil monopotassium | 863031-24-7 | C30H23KN4O8 | 606.62 | CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)[N-]5)C(=O)OCC6=C(OC(=O)O6)C.[K+] |
| EOS-AX4341 | Losartan | 114798-26-4 | C22H23ClN6O | 422.91 | CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl |
| EOS-AX4342 | Tranilast Sodium | 104931-56-8 | C18H16NNaO5 | 349.31 | COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)[O-])OC.[Na+] |
| EOS-AX4343 | Cefoselis | 122841-10-5 | C19H22N8O6S2 | 522.56 | CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=C(N4CCO)N)C(=O)[O-] |
| EOS-AX4344 | Cefoselis hydrochloride | 911212-25-4 | C19H23ClN8O6S2 | 559.02 | CO/N=C(\C(O)=N\[C@]([C@]1([H])N2C(C(O)=O)=C(CS1)CN3C=C/C(N3CCO)=N/[H])([H])C2=O)C(N4)=CSC4=N.Cl |
| EOS-AX4345 | Doripenem | 148016-81-3 | C15H24N4O6S2 | 420.5 | CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O |
| EOS-AX4346 | Cephalexin hydrochloride | 59695-59-9 | C16H18ClN3O4S | 383.85 | CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O.Cl |
| EOS-AX4347 | Cephalexin monohydrate | 23325-78-2 | C16H19N3O5S | 365.4 | CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O.O |
| EOS-AX4348 | BMS-303141 | 943962-47-8 | C19H15Cl2NO4S | 424.3 | COC1=C(NS(C2=CC(Cl)=CC(Cl)=C2O)(=O)=O)C=C(C3=CC=CC=C3)C=C1 |
| EOS-AX4349 | Marinopyrrole A | 1227962-62-0 | C22H12Cl4N2O4 | 510.15 | OC1=CC=CC=C1C(C2=C(N3C(C(C4=CC=CC=C4O)=O)=CC(Cl)=C3Cl)C(Cl)=C(Cl)N2)=O |
| EOS-AX4350 | CPI-203 | 1446144-04-2 | C19H18ClN5OS | 399.9 | CC1=C(C)C(C(C2=CC=C(Cl)C=C2)=N[C@@H](CC(N)=O)C3=NN=C(C)N43)=C4S1 |
| EOS-AX4351 | PCI 29732 | 330786-25-9 | C22H21N5O | 371.44 | NC1=NC=NC2=C1C(C3=CC=C(OC4=CC=CC=C4)C=C3)=NN2C5CCCC5 |
| EOS-AX4352 | LEE011 hydrochloride | 1211443-80-9 | C23H31ClN8O | 471 | CN(C(C(N1C2CCCC2)=CC(C1=N/3)=CNC3=N/C4=NC=C(N5CCNCC5)C=C4)=O)C.Cl |
| EOS-AX4353 | LEE011 succinate | 1374639-75-4 | C27H36N8O5 | 552.63 | CN(C(C(N1C2CCCC2)=CC(C1=N/3)=CNC3=N/C4=NC=C(N5CCNCC5)C=C4)=O)C.O=C(O)CCC(O)=O |
| EOS-AX4354 | LEE011 succinate hydrate | 1374639-79-8 | C27H38N8O6 | 570.64 | CN(C(C(N1C2CCCC2)=CC(C1=N/3)=CNC3=N/C4=NC=C(N5CCNCC5)C=C4)=O)C.O=C(O)CCC(O)=O.O |
| EOS-AX4355 | GlyH-101 | 328541-79-3 | C19H15Br2N3O3 | 493.15 | C1=CC=C2C=C(C=CC2=C1)NCC(=O)NNC=C3C=C(C(=C(C3=O)Br)O)Br |
| EOS-AX4356 | LY2606368 | 1234015-52-1 | C18H19N7O2 | 365.39 | |
| EOS-AX4357 | CMX001 | 444805-28-1 | C27H52N3O7P | 561.69 | CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O |
| EOS-AX4358 | Entacapone sodium salt | 1047659-02-8 | C14H14N3NaO5 | 327.27 | CCN(C(/C(C#N)=C([H])/C1=CC(N(=O)=O)=C(O)C([O-])=C1)=O)CC.[Na+] |
| EOS-AX4359 | Deracoxib | 169590-41-4 | C17H14F3N3O3S | 397.37 | COC1=C(C=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)F)F |
| EOS-AX4360 | Salicylic acid | 69-72-7 | C7H6O3 | 138.12 | C1=CC=C(C(=C1)C(=O)O)O |
| EOS-AX4361 | SCH 546738 | 906805-42-3 | C23H31Cl2N7O | 492.44 | CCC1CN(CCN1C2CCN(CC2)CC3=CC=C(C=C3)Cl)C4=NC(=C(N=C4Cl)C(=O)N)N |
| EOS-AX4362 | NBI-74330 | 855527-92-3 | C32H27F4N5O3 | 605.58 | CCOC1=CC=C(C=C1)N2C(=O)C3=C(N=CC=C3)N=C2C(C)N(CC4=CN=CC=C4)C(=O)CC5=CC(=C(C=C5)F)C(F)(F)F |
| EOS-AX4363 | Sumanirole maleate | 179386-44-8 | C15H17N3O5 | 319.31 | O=C(N([H])C1=C([H])C([H])=C([H])C2=C31)N3C([H])([H])[C@](C2([H])[H])([H])N([H])C([H])([H])[H].O=C(/C([H])=C([H])\C(O[H])=O)O[H] |
| EOS-AX4364 | USP7-USP47 inhibitor | 1247825-37-1 | C18H11Cl2N3O3S3 | 484.4 | CS(C1=CC=C(/N=C(O)/C2=CC(C#N)=C(SC3=C(Cl)C=NC=C3Cl)S2)C=C1)(=O)=O |
| EOS-AX4365 | HBX 19818 | | | | |
| EOS-AX4366 | Altretamine hydrochloride | 2975-00-0 | C9H19ClN6 | 246.74 | CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C.Cl |
| EOS-AX4367 | Daunorubicin | 20830-81-3 | C27H29NO10 | 527.52 | CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O |
| EOS-AX4368 | Cytarabine hydrochloride | 69-74-9 | C9H14ClN3O5 | 279.68 | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl |
| EOS-AX4369 | Mycophenolate mofetil hydrochloride | 116680-01-4 | C23H32ClNO7 | 469.96 | CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC.Cl |
| EOS-AX4370 | Brexpiprazole | 913611-97-9 | C25H27N3O2S | 433.57 | C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4 |
| EOS-AX4371 | Mutant EGFR inhibitor | 1421373-62-7 | C27H30ClN7O2 | 520.03 | C=C/C(O)=N/C1=CC(NC2=NC=C(Cl)C(C3=CNC4=CC=CC=C34)=N2)=C(OC)C=C1N(CCN(C)C)C |
| EOS-AX4372 | AZD-9291 | 1421373-65-0 | C28H33N7O2 | 499.61 | CN1C=C(C2=NC(NC3=C(OC)C=C(N(CCN(C)C)C)C(NC(C=C)=O)=C3)=NC=C2)C4=C1C=CC=C4 |
| EOS-AX4373 | AZD-9291 mesylate | 1421373-66-1 | C29H37N7O5S | 595.71 | C=C/C(O)=N/C1=CC(NC2=NC=CC(C(C3=CC=CC=C34)=CN4C)=N2)=C(OC)C=C1N(CCN(C)C)C.CS(O)(=O)=O |
| EOS-AX4374 | VRT752271 | 869886-67-9 | C21H22Cl2N4O2 | 433.33 | CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl |
| EOS-AX4375 | (R)-Baclofen hydrochloride | 63701-55-3 | C10H13Cl2NO2 | 250.12 | C1=CC(=CC=C1C(CC(=O)O)CN)Cl.Cl |
| EOS-AX4376 | Ro 28-1675 | 300353-13-3 | C18H22N2O3S2 | 378.51 | CS(=O)(=O)C1=CC=C(C=C1)C(CC2CCCC2)C(=O)NC3=NC=CS3 |
| EOS-AX4377 | GPR40 Activator 1 | 1309435-60-6 | C31H31NO3S | 497.65 | CC#C[C@@](C1=CC(OCC2=CC=C(S2)CN3CCC4(CC3)C=CC5=CC=CC=C54)=CC=C1)([H])CC(O)=O |
| EOS-AX4378 | GSK-3 inhibitor 1 | 603272-51-1 | C22H17ClFN5O2 | 437.85 | FC1=CC2=C3C(CNCCN3C=C2C(C(O)=NC4=O)=C4C5=CN=C6C=CC=CN56)=C1.Cl |
| EOS-AX4379 | N6022 | 1208315-24-5 | C24H22N4O3 | 414.46 | CC1=C(C=CC(=C1)C(=O)N)N2C(=CC=C2C3=CC=C(C=C3)N4C=CN=C4)CCC(=O)O |
| EOS-AX4380 | Merimepodib | 198821-22-6 | C23H24N4O6 | 452.46 | COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4 |
| EOS-AX4381 | ABT-333 | 1132935-63-7 | C26H27N3O5S | 493.57 | CC(C)(C)C1=C(C(=CC(=C1)N2C=CC(=O)NC2=O)C3=CC4=C(C=C3)C=C(C=C4)NS(=O)(=O)C)OC |
| EOS-AX4382 | T 705 | 259793-96-9 | C5H4FN3O2 | 157.1 | C1=C(N=C(C(=O)N1)C(=O)N)F |
| EOS-AX4383 | BAY 87-2243 | 1227158-85-1 | C26H26F3N7O2 | 525.53 | CC1=CC(C2=NC(C3=CC=C(OC(F)(F)F)C=C3)=NO2)=NN1CC4=CC=NC(N5CCN(C6CC6)CC5)=C4 |
| EOS-AX4384 | Mizolastine dihydrochloride | 1056596-82-7 | C24H27Cl2FN6O | 505.42 | CN(C1=NC=CC(O)=N1)C2CCN(C3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)CC2.Cl.Cl |
| EOS-AX4385 | Azatadine | 3964-81-6 | C20H22N2 | 290.4 | CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1 |
| EOS-AX4386 | Mianserin | 24219-97-4 | C18H20N2 | 264.36 | [H]C1(C2=C([H])C([H])=C([H])C([H])=C2C([H])([H])C3=C([H])C([H])=C([H])C([H])=C43)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C1([H])[H] |
| EOS-AX4387 | Efavirenz | 154598-52-4 | C14H9ClF3NO2 | 315.68 | C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F |
| EOS-AX4388 | BMS-538203 | 543730-41-2 | C12H12FNO5 | 269.23 | CON(CC1=CC=C(C=C1)F)C(=O)C=C(C(=O)O)O |
| EOS-AX4389 | TAK-779 | 229005-80-5 | C33H39ClN2O2 | 531.13 | CC1=CC=C(C=C1)C2=CC3=C(CCCC(=C3)C(=O)NC4=CC=C(C=C4)C[N+](C)(C)C5CCOCC5)C=C2.[Cl-] |
| EOS-AX4390 | Nelfinavir | 159989-64-7 | C32H45N3O4S | 567.78 | CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O |
| EOS-AX4391 | Rosuvastatin | 287714-41-4 | C22H28FN3O6S | 481.54 | CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C |
| EOS-AX4392 | Pitavastatin | 147511-69-1 | C25H24FNO4 | 421.46 | C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F |
| EOS-AX4393 | Pravastatin | 81093-37-0 | C23H36O7 | 424.53 | CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O |
| EOS-AX4394 | UNC0321 | 1238673-32-9 | C27H45N7O3 | 515.69 | CN1CCCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)NC4CCN(CC4)C)OC)OCCOCCN(C)C |
| EOS-AX4395 | UNC 0631 | 1320288-19-4 | C37H61N7O2 | 635.93 | COC1=C(OCCCN2CCCCC2)C=C3C(C(NC4CCN(CC5CCCCC5)CC4)=NC(N6CCN(C(C)C)CCC6)=N3)=C1 |
| EOS-AX4396 | Mutant IDH1 inhibitor | 1429180-08-4 | C25H34N6O3 | 466.58 | CC([C@@](N1C2=NC(N[C@@](C3=CC=C(CN4CCN(C(C)=O)CC4)C=C3)([H])C)=NC=C2)([H])COC1=O)C |
| EOS-AX4397 | GLPG0634 | 1206161-97-8 | C21H23N5O3S | 425.5 | C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5 |
| EOS-AX4398 | Xanomeline oxalate | 141064-23-5 | C16H25N3O5S | 371.45 | CCCCCCOC1=NSN=C1C2=CCCN(C2)C.C(=O)(C(=O)O)O |
| EOS-AX4399 | Tarafenacin | 385367-47-5 | C21H20F4N2O2 | 408.39 | C1CN2CCC1C(C2)OC(=O)N(CC3=CC(=C(C(=C3)F)F)F)C4=CC(=CC=C4)F |
| EOS-AX4400 | Tarafenacin D-tartrate | 1159101-48-0 | C25H26F4N2O8 | 558.48 | C1CN2CCC1C(C2)OC(=O)N(CC3=CC(=C(C(=C3)F)F)F)C4=CC(=CC=C4)F.C(C(C(=O)O)O)(C(=O)O)O |
| EOS-AX4401 | Oxybutynin chloride | 1508-65-2 | C22H32ClNO3 | 393.95 | CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl |
| EOS-AX4402 | GDC-0623 | 1168091-68-6 | C16H14FIN4O3 | 456.21 | C1=CC(=C(C=C1I)F)NC2=C(C=CC3=CN=CN32)C(=O)NOCCO |
| EOS-AX4403 | Nemorubicin | 108852-90-0 | C32H37NO13 | 643.64 | CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N6CCOC(C6)OC)O |
| EOS-AX4404 | GSK962040 hydrochloride | 923565-22-4 | C25H34ClFN4O | 461.02 | C[C@@]1([H])CN(CC2=CC=C(CC(N3CCC(NC4=CC=CC(F)=C4)CC3)=O)C=C2)CCN1.Cl |
| EOS-AX4405 | Mps1-IN-2 | 1228817-38-6 | C26H36N6O3 | 480.6 | CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(CCC(=O)N4C)C5CCCC5 |
| EOS-AX4406 | ML314 | 1448895-09-7 | C24H28N4O3 | 420.5 | COC1=CC=CC=C1N2CCN(CC2)C3=NC(=NC4=CC(=C(C=C43)OC)OC)C5CC5 |
| EOS-AX4407 | Varenicline | 249296-44-4 | C13H13N3 | 211.26 | [H]C1(C([H])([H])N([H])C2([H])[H])C([H])([H])[C@]2([H])C3=C([H])C4=NC([H])=C([H])N=C4C([H])=C13 |
| EOS-AX4408 | Varenicline Hydrochloride | 230615-23-3 | C13H14ClN3 | 247.72 | Cl[H].[H]C1(C([H])([H])N([H])C2([H])[H])C([H])([H])[C@]2([H])C3=C([H])C4=NC([H])=C([H])N=C4C([H])=C13 |
| EOS-AX4409 | SDZ 220-581 hydrochloride | 179411-93-9 | C16H18Cl2NO5P | 406.2 | ClC1=CC=CC=C1C2=CC(C[C@@](N)([H])C(O)=O)=CC(CP(O)(O)=O)=C2.Cl |
| EOS-AX4410 | Ro 25-6981 | 169274-78-6 | C22H29NO2 | 339.47 | C[C@@]([C@](O)([H])C1=CC=C(O)C=C1)([H])CN2CCC(CC3=CC=CC=C3)CC2 |
| EOS-AX4411 | Ro 25-6981 Maleate | 1312991-76-6 | C26H33NO6 | 455.54 | OC1=CC=C([C@@H](O)[C@@H](C)CN2CCC(CC3=CC=CC=C3)CC2)C=C1.O=C(O)/C=C\C(O)=O |
| EOS-AX4412 | Felbamate hydrate | 1177501-39-1 | C11H16N2O5 | 256.26 | N=C(OCC(C1=CC=CC=C1)COC(O)=N)O.O |
| EOS-AX4413 | MCOPPB trihydrochloride | 1108147-88-1 | C26H43Cl3N4 | 518.01 | CC1(CCCCCCC1)N2CCC(CC2)N3C4=CC=CC=C4N=C3C5CCCNC5.Cl.Cl.Cl |
| EOS-AX4414 | Orotic acid | 65-86-1 | C5H4N2O4 | 156.1 | C1=C(NC(=O)NC1=O)C(=O)O |
| EOS-AX4415 | GSK962040 | 923565-21-3 | C25H33FN4O | 424.55 | CC1CN(CCN1)CC2=CC=C(C=C2)CC(=O)N3CCC(CC3)NC4=CC(=CC=C4)F |
| EOS-AX4416 | NSI-189 | 1270138-40-3 | C22H30N4O | 366.5 | CC(C)CCNC1=C(C=CC=N1)C(=O)N2CCN(CC2)CC3=CC=CC=C3 |
| EOS-AX4417 | Gadobutrol | 770691-21-9 | C18H31GdN4O9 | 604.71 | C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])C(CO)C(CO)O)CC(=O)[O-].[Gd+3] |
| EOS-AX4418 | DL-threo-2-methylisocitrate | 71183-66-9 | C6H8O7 | 192.12 | O=C(O)C[C@](C(O)=O)([H])[C@@](O)([H])C(O)=O |
| EOS-AX4419 | Oxonic acid potassium salt | 2207-75-2 | C4H2KN3O4 | 195.17 | C1(=NC(=O)NC(=O)N1)C(=O)[O-].[K+] |
| EOS-AX4420 | Adrafinil | 63547-13-7 | C15H15NO3S | 289.35 | C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)NO |
| EOS-AX4421 | Sunifiram | 314728-85-3 | C14H18N2O2 | 246.3 | CCC(=O)N1CCN(CC1)C(=O)C2=CC=CC=C2 |
| EOS-AX4422 | sn-Glycero-3-phosphocholine | 28319-77-9 | C8H20NO6P | 257.22 | C[N+](C)(C)CCOP(=O)([O-])OCC(CO)O |
| EOS-AX4423 | Coluracetam | 135463-81-9 | C19H23N3O3 | 341.4 | CC1=C(OC2=NC3=C(CCCC3)C(=C12)NC(=O)CN4CCCC4=O)C |
| EOS-AX4424 | (R)-Oxiracetam | 68252-28-8 | C6H10N2O3 | 158.16 | C1C(CN(C1=O)CC(=O)N)O |
| EOS-AX4425 | Meclofenoxate hydrochloride | 3685-84-5 | C12H17Cl2NO3 | 294.17 | CN(C)CCOC(=O)COC1=CC=C(C=C1)Cl.Cl |
| EOS-AX4426 | SB 242235 | 193746-75-7 | C19H20FN5O | 353.39 | COC1=NC=CC(=N1)C2=C(N=CN2C3CCNCC3)C4=CC=C(C=C4)F |
| EOS-AX4427 | FRAX597 | 1286739-19-2 | C29H28ClN7OS | 558.1 | CCN1C2=NC(=NC=C2C=C(C1=O)C3=C(C=C(C=C3)C4=CN=CS4)Cl)NC5=CC=C(C=C5)N6CCN(CC6)C |
| EOS-AX4428 | MK-4827 hydrochloride | 1038915-64-8 | C19H21ClN4O | 356.85 | C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N.Cl |
| EOS-AX4429 | MK-4827 tosylate | 1038915-73-9 | C26H28N4O4S | 492.59 | N=C(O)C1=CC=CC(C1=N2)=CN2C3=CC=C([C@]4([H])CCCNC4)C=C3.CC5=CC=C(S(O)(=O)=O)C=C5 |
| EOS-AX4430 | Pimobendan hydrochloride | 77469-98-8 | C19H19ClN4O2 | 370.83 | CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC.Cl |
| EOS-AX4431 | Dofequidar | 129716-58-1 | C30H31N3O3 | 481.59 | C1CN(CCN1CC(COC2=CC=CC3=C2C=CC=N3)O)C(=O)C(C4=CC=CC=C4)C5=CC=CC=C5 |
| EOS-AX4432 | Dofequidar fumarate | 153653-30-6 | C34H35N3O7 | 597.66 | OC(COC1=CC=CC2=C1C=CC=N2)CN3CCN(C(C(C4=CC=CC=C4)C5=CC=CC=C5)=O)CC3.O=C(O)/C([H])=C([H])/C(O)=O |
| EOS-AX4433 | CAY10650 | 1233706-88-1 | C28H25NO6 | 471.5 | CC(C)C(=O)C1=CN(C2=C1C=C(C=C2)C(=O)O)CC(=O)COC3=CC=C(C=C3)OC4=CC=CC=C4 |
| EOS-AX4434 | GSK 2830371 | 1404456-53-6 | C23H29ClN4O2S | 461.02 | CC1=C(NCC(S2)=CC=C2C(N[C@@](/C(O)=N/C3CC3)([H])CC4CCCC4)=O)C=C(Cl)C=N1 |
| EOS-AX4435 | PI3Kγ inhibitor 1 | 1172118-03-4 | C32H26N8O2S | 586.67 | CC1=CC=CC=C1N2C(=CC3=C(C2=O)C(=CC=C3)C)CN4C5=C(C(=N4)C6=CC7=C(C=C6)N=C(S7)NC(=O)C)C(=NC=N5)N |
| EOS-AX4436 | NVP-QAV-572 | 957209-68-6 | C17H19F2N7O3S2 | 471.5 | CC(N=C1N/C(O)=N/CCC(N=N2)=NN2CCF)=C(S1)C3=CC(F)=C(S(C)(=O)=O)C=C3 |
| EOS-AX4437 | B-Raf inhibitor 1 | 1093100-40-3 | C26H19ClN8 | 478.94 | CC1=C(C2=C(C=C1)C(=NC=C2)NC3=CC=C(C=C3)Cl)NC4=C(C=CC=N4)C5=C6C(=NC=N5)N=CN6 |
| EOS-AX4438 | B-Raf inhibitor 1 dihydrochloride | 1191385-19-9 | C26H21Cl3N8 | 551.86 | CC1=C(C2=C(C=C1)C(=NC=C2)NC3=CC=C(C=C3)Cl)NC4=C(C=CC=N4)C5=C6C(=NC=N5)N=CN6.Cl.Cl |
| EOS-AX4439 | LGX818 | 1269440-17-6 | C22H27ClFN7O4S | 540.01 | CC(C)N1C=C(C(=N1)C2=CC(=CC(=C2F)NS(=O)(=O)C)Cl)C3=NC(=NC=C3)NCC(C)NC(=O)OC |
| EOS-AX4440 | Palovarotene | 410528-02-8 | C27H30N2O2 | 414.54 | CC1(CCC(C2=C1C=C(C(=C2)C=CC3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C |
| EOS-AX4441 | Y-39983 dihydrochloride | 173897-44-4 | C16H18Cl2N4O | 353.25 | CC(C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N.Cl.Cl |
| EOS-AX4442 | Nafamostat | 81525-10-2 | C19H17N5O2 | 347.37 | C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N |
| EOS-AX4443 | Nafamostat hydrochloride | 80251-32-7 | C19H19Cl2N5O2 | 420.29 | NC(C1=CC2=CC=C(OC(C3=CC=C(NC(N)=N)C=C3)=O)C=C2C=C1)=N.Cl.Cl |
| EOS-AX4444 | S1RA | 878141-96-9 | C20H23N3O2 | 337.42 | CC1=CC(OCCN2CCOCC2)=NN1C3=CC4=CC=CC=C4C=C3 |
| EOS-AX4445 | S1RA hydrochloride | 1265917-14-3 | C20H24ClN3O2 | 373.88 | |
| EOS-AX4446 | Nav1.7 inhibitor | 1355631-24-1 | C15H11Cl3FNO4S | 426.67 | CS(=O)(=O)NC(=O)C1=CC(=C(C=C1F)COC2=CC(=C(C=C2)Cl)Cl)Cl |
| EOS-AX4447 | ABC294640 | 915385-81-8 | C23H25ClN2O | 380.91 | C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl |
| EOS-AX4448 | Escitalopram | 128196-01-0 | C20H21FN2O | 324.39 | CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F |
| EOS-AX4449 | Milnacipran | 92623-85-3 | C15H22N2O | 246.35 | CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2 |
| EOS-AX4450 | TGR5 Receptor Agonist | 1197300-24-5 | C18H14Cl2N2O2 | 361.22 | CC1=C(C(N(C2=CC=C(Cl)C=C2)C)=O)C(C3=CC=CC=C3Cl)=NO1 |
| EOS-AX4451 | Imiquimod hydrochloride | 99011-78-6 | C14H17ClN4 | 276.76 | CC(CN1C=NC2=C1C3=CC=CC=C3NC2=N)C.Cl |
| EOS-AX4452 | Imiquimod maleate | 896106-16-4 | C18H20N4O4 | 356.38 | CC(CN1C=NC2=C1C3=CC=CC=C3NC2=N)C.O=C(O)/C([H])=C([H])\C(O)=O |
| EOS-AX4453 | Lenalidomide hemihydrate | 847871-99-2 | C26H28N6O7 | 536.54 | NC1=CC=CC(C2=O)=C1CN2C3CCC(O)=NC3=O.NC4=CC=CC(C5=O)=C4CN5C6CCC(O)=NC6=O.O |
| EOS-AX4454 | TRPC6 inhibitor | 1333207-63-8 | C21H24Cl3N3O | 440.79 | ClC1=C(O[C@]2([H])C3=CC=CC=C3C[C@@]2([H])N4CCC[C@](N)([H])C4)C=CC(C#N)=C1.Cl.Cl |
| EOS-AX4455 | CC0651 | 1319207-44-7 | C20H21Cl2NO6 | 442.29 | COC/C(O)=N/[C@@]([C@@](O)([H])[C@](O)([H])C(O)=O)([H])CC1=CC=C(C2=CC(Cl)=CC(Cl)=C2)C=C1 |
| EOS-AX4456 | 25,26-Dihydroxyvitamin D3 | 29261-12-9 | C27H44O3 | 416.64 | CC(CCCC(C)(CO)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C |
| EOS-AX4457 | Topiroxostat | 577778-58-6 | C13H8N6 | 248.24 | C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N |
| EOS-AX4458 | PF-3084014 | 1290543-63-3 | C27H41F2N5O | 489.64 | |
| EOS-AX4459 | TAK-700 R-form | 752243-39-3 | C18H17N3O2 | 307.35 | CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)C3(CCN4C3=CN=C4)O |
| EOS-AX4460 | Finasteride acetate | 222989-99-3 | C25H40N2O4 | 432.6 | |
| EOS-AX4461 | Risperidone hydrochloride | 666179-74-4 | C23H28ClFN4O2 | 446.95 | CC(N=C1CCCCN12)=C(C2=O)CCN3CCC(C4=NOC5=C4C=CC(F)=C5)CC3.Cl |
| EOS-AX4462 | Risperidone mesylate | 666179-96-0 | C24H31FN4O5S | 506.59 | CC(N=C1CCCCN12)=C(C2=O)CCN3CCC(C4=NOC5=C4C=CC(F)=C5)CC3.CS(O)(=O)=O |
